Jul 2016

THE MAGAZINE FOR NEW ZEALAND’S OPHTHALMIC COMMUNITY
PO BOX 106 954, AUCKLAND CITY 1143
Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz
JULY 2016
NOW AVAILABLE WITH
WWW.EYEZEN.CO.NZ

10 free ticket,
flight and
hotel packages
available now!
YOUR PERSONAL INVITATION
BRISBANE CONVENTION & EXHIBITION CENTRE
SATURDAY 10 TH & SUNDAY 11 TH SEPTEMBER 2016
Join 500 optometrists (including more than 100 non-Specsavers
optometrists) at this year’s SCC for two days in September –
for one of Australia and New Zealand’s premier optometry CPD and
networking events.
Saturday – Clinical Education Sessions: Afternoon session across two concurrent
streams (Therapeutic / Clinical Skills). University, Optometry and Hospital led.
Worth 3 CD Pts and 3 General Pt in 2015.
Sunday – Specsavers Clinical Conference: Full day session on a single stream
(Therapeutic and Clinical topics). Ophthalmology led.
Worth 6 CD Pts and 1 General Pts in 2015. Exhibition also in place.
To find out more and to access the SCC Booking Portal (ticket registration and
accommodation), go to spectrum-blog.com/book/SCC
Non-Specsavers Optometrists: to enter into a prize draw
for ten free ticket / flight / accommodation packages, contact
Sinead Convery on +61 427 754 076 or sinead.convery@specsavers.com
When: Saturday 10th and Sunday 11th September 2016
Where:
Theme:
Detail &
Costs:
Brisbane Convention & Exhibition Centre
‘Collaborative Care – a new era in eye health’
Saturday: Clinical Education Sessions
12:00pm to 5:00pm
$150 + GST
Saturday: Welcome Event
Gallery of Modern Art
6:45pm to 10:45pm
Event hosted by the Specsavers
Professional Services team: no charge
Sunday: SCC
7:30am to 6:00pm
$340 + GST
NZ Franchise
System of
the Year
2014
Retail
Innovator
of the Year
2014
Multichannel
Retailer
of the Year
2014
Roy Morgan
Research
No. 1 for eye tests
2014
FCA International
Franchisor
of the Year
2014
FCA Social
Responsibility
Award
2014
FCA Established
Franchisor
of the Year
2013
FCA Excellence
in Marketing
Award Winner
2013
Australian
Retailer
of the Year
2013
Australian
Retail Employer
of the Year
2013
Asia-Pacific Best
Retail Training
Organisation
2013
2 NEW ZEALAND OPTICS July 2016

New diploma for Foundation
A culmination of three years of hard work means that staff can now receive a
transferable qualification accredited by the NZQA.
O-what a
great month
EDITORIAL
A staff member assists a client during an orientation exercise
BY JAI BREITNAUER
Ask most people what the Blind Foundation
do and they will probably say something
about guide dogs or braille. The truth is they
offer a network of highly trained, specialist support
staff, nationwide, to help people with vision
impairment manage their needs both physically
and emotionally.
This necessary work has always suffered
from one major issue – the flow of staff with
specialist training can wax and wane and even
dry up altogether, making it hard for the Blind
Foundation to predict their staffing needs to meet
future demands.
Learning to navigate outside the home
“Prior to 1990, we recruited our trained staff
from overseas,” says Teresa Bradfield, executive
director of client services. “Having people who
could help people who use our services manage
their daily living needs and getting around safely
was a primary focus for us and we were able to
cherry pick the best performers from Europe and
America.”
Then for a period of time in the ‘90s Massey
University prepared staff with the requisite
qualifications, but financially this was simply
not sustainable for the Blind Foundation. So
the organisation reverted back to the overseas
recruitment model in the early 2000s, but even
overseas the industry was beginning to suffer the
same problems as here in NZ.
With such a small, critical mass of professionals
needed to deliver services, workforce flow and
quality became an issue and the Blind Foundation
found that a lack of available staff – domestically
and internationally – had the potential to impact
the quality of the services they were able to
deliver.
Then in 2013, as part of the NZQA national
qualifications framework shake up, the Blind
Foundation had the chance to work with
Career Force—the country’s Industry Training
Organisation for the health and wellbeing
sectors—to develop a new qualification pathway.
“We’ve had wonderful support from Career
Force,” says professional practice leader
Jane Moore. “We had originally envisaged a
qualification on the NZQA framework that would
take us up to level 6 – a diploma. But with the
help of Career Force our qualification will be
level 7, which is a graduate diploma or Bachelor’s
degree, and some of our critical papers are at the
level 8 standard.”
The graduate diploma has been divided into
four strands to help focus on the area of need.
The Daily Living strand is about providing staff
with the tools to help people who are blind or
have low vision carry out their normal day-to-day
activities. Things that we take for granted, such
as reading labels or pouring fluids, working with
cooking equipment, can be a serious challenge
for those with vision loss. The Technology
and Communication strand is all about the
equipment that can assist the client in having
access to information, keep in touch socially and
participate in reading just as sighted individuals
do. “Technology can be a game changer,” says
Moore, who has been working on the content
of the diploma. “We help clients learn to use
technology like touch screens and braille.”
The Orientation and Mobility strand helps
clients learn to navigate both inside the home
and travel beyond the home, and to use devices
that help them do this, such as GPS. Finally,
the Low Vision Therapy strand is designed
to complement assistance already provided
from other eye and health care professionals,
by helping clients use tools they have been
prescribed in a customised way, specific to their
environment. For example, the Blind Foundation
might help set up a magnifier in a position where
there will be reduced sun-glare.
The ultimate goal is to give clients the tools they
need to live independently in their own home.
Those registered for the diploma can focus on one or
two strands, or part of those strands, depending on
where the predicted need lies.
“We have designed the diploma to be a
qualification you gain while at work,” says Moore.
“You have to be working within the field in order
to study for it and many of our staff members are
over 40; this is the second wave of their career. We
listened to them and felt that studying on the job
was more appropriate for their needs than sending
people back to university.”
The diploma has also been designed so that the
Blind Foundation can predict a future skills deficit,
and fill it by targeting diploma study into the
relevant areas. The diploma is also transferrable to
other care-related industries and can form part of a
building block for a wider qualification. This not only
guarantees a flow of highly qualified staff for the
Blind Foundation, but it offers those studying for the
diploma job security, as well as the wider benefit of
upskilling Kiwis in a way that will be useful even if
they decide to change careers.
“For us, it’s all about identifying core outcomes,
and having a qualification flexible enough to meet
those needs,” says Bradfield. “Demand will influence
how we deliver training and we’re really looking
forward to understanding how that will impact on
our organisation.”
The team at the Blind Foundation are in the last
stages of sign-off with the NZQA and are aiming
to launch the diploma for the academic year
commencing in 2017. They have already received
a high level of interest from their staff and hope
this training opportunity will draw more interested
parties to want to work for the organisation and
raise their profile among other healthcare providers.
“We know there are a significant number of
potential clients out there who never reach
our door,” says Bradfield. “We’d be delighted
to receive more referrals from optometrists
and ophthalmologists working with low vision
patients. We want to collaborate with eye health
professionals to achieve the best outcome for the
client.
“We’re here, feel free to get in touch.”
If you have any questions about the services
provided by the Blind Foundation or want to know
more about the new diploma, call 0800243333 or
visit blindfoundation.org.nz ▀
The brand new boutique offering from
ODMA, the O-Show, kicked off a great
month of events. With its twinkling
fairy-lights and inviting Melbourne docklands
venue, the O-Show created a camaraderie of
feeling that made it a pleasure for delegates,
including yours truly, to attend. We have pics,
stats and all the news from this new event,
including details about some fantastic new
frames coming our way. I even came home with
a fabulous pair of Jono Hennessy’s – thanks
Louise – and a new columnist, the passionate
and exceptionably knowledgeable on allthings-frames
Jo Eaton, who debuts in this
month’s issue.
And then there was RANZCO NZ, our first New
Zealand branch meeting, which was oh so much
more enjoyable than the somewhat daunting
Australasian event in early November last year
– though the daunting’ness of it had as much to
do with my newness to the industry as the size
of the event! What a pleasure to actually spend
some time with the country’s ophthalmologists,
meet some awe-inspiring ophthalmic nurses
and learn about the new technologies out
there. The artificial iris (detailed in the RANZCO
NZ supplement) was simply fascinating.
The Eye Institute also kicked off its seminar
series (in this issue) and Eye Doctors held their
second Grand Round, though we’ll be covering
that next month as there simply wasn’t room to
do it justice this month.
All that coupled with some incredible
achievements by our DOs and optometrists on
the world stage (see news) and O-O-O it has
been a really great month. Happy Helen Keller’s
birthday for the 27 June too. Enjoy. ▀
Stem cell cure for
cataracts in sight
In the world of medicine, regenerative
treatments are somewhat of a holy grail. Still
frustratingly futuristic in their development
however, it’s heartening to know good progress
is being made in certain areas.
One study published in the journal Nature
earlier this year reports how a dozen infants
born with cataracts were successfully treated
as part of a research programme into stem
cell cures. The research, a joint effort between
the University of San Diego and Sun Yat-sen
University in Guangzhou, China, was inspired
by a side effect of implanting artificial lenses to
treat cataracts—the patient’s own cells often
grow over the new lenses, making them cloudy.
Using that basic principle, the team set out to
discover if the body was capable of regenerating
an entire lens.
They began with a series of animal studies to
assess whether lens epithelial stem/progenitor
cells (LECs) that exist naturally in a fully-formed
mammalian eye can produce a new lens. The
results were encouraging and they moved on to
developing a surgical technique they tested on a
variety of animals, including rabbits and macaque
monkeys and then on 12 human babies.
The surgery involved slicing a 1.5mm opening
in the side of the lens capsule and removing the
diseased lens without replacing it, prompting the
eye’s LECs to start growing a new one; a process
that takes around three months. The results have
been very positive, with the first child operated
on two years ago still showing very good vision
and the complication rate seemingly very low
at just 17%, compared to 92% with traditional
replacement surgery, the researchers reported.
Whether this technique can be extended is
Enjoying the company at RANZCO NZ 2016
Lesley Springall, publisher, NZ Optics
A white congenital cataract. (US National Eye Institute)
debatable though as most cataract patients
are quite elderly and so their bodies will have
a naturally lower rate of regeneration, and the
eye may not regenerate at all. Babies born with
cataracts also often have genetic mutations which
could cause the condition to re-occur, but ongoing
monitoring of the current test group is showing a
positive prognosis right now, said researchers.
“This is without doubt one of the most exciting
developments in cataract surgery in many years
– as evidenced by the prominent publication
of the research study in Nature, the most
prestigious journal in the biomedical field,” said
Professor Charles McGhee, senior ophthalmic
surgeon at Auckland City hospital and head of
the Department of Ophthalmology at Auckland
University.
“Whether this pioneering work can be
translated into techniques applicable to adult
cataract remains to be seen, but this may well
provide a new avenue for the management of
congenital cataract.” ▀
For more see Focus on Eye Research p13.
July 2016
NEW ZEALAND OPTICS
3

News
in brief
WHERE ARE MY GLASSES?
A question that may fall out of fashion, thanks to the folks at
iHuman who has launched a new range of ‘adaptable eyewear’
called FindMe, which allows you to find your glasses, thanks to a
simple smartphone application. Even more impressive, the system
works both ways, allowing your glasses to find your phone if you
lose it. Using the FindMe app and the integrated radar system, your
phone shows you the direction of your misplaced glasses, while a
button activates a buzzer present in the frame.
PHOTOBIOMODULATION IMPROVES BCVA
LumiThera announced a significant improvement in visual acuity,
contrast sensitivity and retinal drusen volume in patients with dry
age-related macular degeneration when treated with non-invasive
photobiomodulation, according to study results presented at
ARVO. Over a three-week course, an LED light comprising of red
(670 nm), yellow (590 nm) and infrared (790 nm) was applied to 24
subjects’ eyes. Researchers found a statistically significant mean
improvement in both ETDRS BCVA of +5.9 letters and contrast
sensitivity +0.11 log units at three cycles per degree, which lasted
for three months.
SIGNIFICANT REDUCTION IN CME POST CATARACT SURGERY
Investigators from Imprimis Pharmaceuticals announced positive
clinical study results with its triamcinolone acetonide, moxifloxacin
HCl and vancomycin dropless therapy formation in patients after
cataract surgery at the ASCRS. The study prospectively compared
rates of post-operative cystoid macular oedema (CME) using
traditional steroid and nonsteroidal anti-inflammatory drops
with triamcinolone acetonide, moxifloxacin HCl and vancomycin
dropless therapy (Tri-Moxi-Vanc) combined with an NSAID drop,
in a total of 1,200 consecutive surgeries. In the 600 patients in the
historical group using NSAID and steroid drops, the CME rate was
1.5%, while in the other group, the CME rate was 0.5%.
BLINDNESS EXPECTED TO DOUBLE BY 2050
The number of Americans with visual impairment or blindness
is expected to double to more than 8 million by 2050, according
to projections and studies funded by the National Eye Institute,
with another 16.4 million expected to have difficulty seeing due
to correctable refractive errors such as myopia or hyperopia.
Researchers estimated 1 million Americans were legally blind
in 2015.
FLYING EYE-DOCTORS LAUNCHED
Orbis has launched–quite literally–the world’s only mobile
ophthalmic teaching hospital located on an MD-10 aircraft. A
culmination of six-years of work, the Orbis plane features stateof-the-art
technologies to allow surgeon volunteers to teach
physicians in developing countries about treatments and safety
standards for cataract, glaucoma, refractive errors, diabetes-related
conditions, strabismus and more. The hospital is the only nonland-based
hospital that has been accredited by the American
Association for Accreditation of Ambulatory Surgical Facilities
International. The new teaching facility was unveiled on 2 June and
is currently touring the US before departing to Asia to conduct its
inaugural programme in Shenyang, China this September.
META-LENSES SET TO REVOLUTIONISE OPTICS
Researchers from Harvard University have developed a new type
of flat lens that could replace more cumbersome curved glass
optics currently used in a wide range of imaging appliances. The
planar lens is capable of processing images of objects smaller than
even the best microscopes, using a titanium dioxide-based array
of nanostructures. The new optic, called a metalense, also has
better focusing power than traditional glass lenses and measures a
fraction of a millimetre in thickness. Researchers say the technology
could have applications in virtual reality headsets, space telescopes
and even contact lenses.
ESSILOR AWARD
Essilor was named No.5 in Newsweek’s 2016 Green Rankings, which
assess the overall environmental performance of the 500 largest
publicly traded companies in the US and the 500 largest publicly
traded companies globally. In a statement announcing the placing,
Essilor said it had reduced water consumption by 40% and energy
consumption by 22% in its mass production plants over the last
seven years.
GLAUCOMA REPORT KEY FINDINGS ANNOUNCED
Spending on glaucoma drugs is expected to surpass US$6 billion
globally by the end of 2016 according to the just released Glaucoma
Drugs Market: 2016 – 2030 report. Generic variants of glaucoma
drugs, such as Latanoprost, continue to gain traction as patents of
innovator formulations expire. New glaucoma R&D programmes
are primarily focused on ROCK (Rho Kinase) inhibitors, adenosine
agonists and NO (Nitric Oxide) donors, among other therapies.
Some drug developers are also investing in sustained release
product candidates, for existing prostaglandin analogues and other
drugs, to address the issue of non-adherence. ▀
Changes afoot at GenOp
Brad Saffin, GenOp ANZ country managing director
General Optical, one of New
Zealand’s leading suppliers of
eyewear and services to the
country’s independent optometry sector
is closing its Christchurch-based New
Zealand office to improve its focus on
New Zealand.
“This change will give us greater capacity
to meet the needs of our New Zealand
customers by leveraging our significant
resources based in our Sydney office,”
New low vision clinic
A
new, private low vision clinic has
launched at Southern Eye Specialists
in Christchurch, to meet client
demand. The clinic, which launched in April,
is being run by Merivale optometrist John
Veale, who has worked with low vision
patients since 1986.
“The current waiting time for the free
clinic I run is about six weeks,” said Veale.
“There was a demand for a private clinic
with a shorter wait time and Dr Jim
Borthwick asked me to be involved.”
Dr Borthwick admits to being very
interested in the area of low vision and has
been using a MAIA microperimetry machine
for around 18 months with very promising
results. Only the second machine of its
type in New Zealand, the MAIA machine
is used for visual function diagnosis and
improvement and in clinical trials has
shown itself to be particularly useful when
a patient has good visual acuity that gives
little clue to an underlying problem.
“I bought the machine to use in the
2RT trial we are currently running with
age-related Macular Degeneration (MD)
patients, as it provides very accurate
and repeatable test results,” explains Dr
Borthwick. “But I have been very pleased
with the scope of usefulness of the
machine.”
One key area of use for the MAIA machine
is retraining MD patients to use the edge of
their vision to read.
“The machine tests how well a patient
Luxottica closes Sydney distribution
The distribution centre (DC) for Luxottica
in Sydney will close from November
this year.
In a statement announcing the closure in
early June, the president of optical retail,
Australia and New Zealand, Anthea Muir
said: “At Luxottica we are constantly looking
at ways to improve our effectiveness and in
turn, serve our customers more quickly and
efficiently. On a local level, this means better
leveraging our master distribution hub in
Dongguan, China, allowing us to centralise
and strengthen our service to the important
Asia-Pacific region.
“Bringing the regional work into a single
facility will give us a tighter footprint and
ensure a strong position in stock levels
at all times, a critical tool in serving the
customer.”
Currently, the wholesale side of the
business is served directly from the Asia-
explains Brad Saffin, Australia and New
Zealand country managing director of
General Optical.
New Zealand customers will still have
support and product supplied through a
New Zealand-based sales team and product
will continue to be shipped from Sydney. But
the New Zealand customer service line will
now be answered by the customer service
team based in Sydney, which should improve
service by directly connecting New Zealand
optometry practices to GenOp’s main office
in Sydney, says Saffin.
The changes came into effect on 1 June,
but the company’s still working through
some of the details with its yet-to-be
finalised New Zealand-based sales team.
GenOp has also informed its existing New
Zealand customers of the changes in person
and via email, says Saffin, and has received
positive feedback for the changes.
The company is not just a frames supplier,
stressed Saffin, but prefers to consider itself a
partner to independent optometry practices,
providing a comprehensive integrated supply
chain, including practice management
software, a broad range of product offerings,
marketing support and educational training.
“General Optical offers a comprehensive
holds fixation,” says Dr
Borthwick. “The machine can
assess the area with the least
degeneration, that is most
visually sensitive, and you can
train patients to look in that
direction – to use the edge of
their vision, rather than their
central vision, to read.”
After 10 sessions with the
MAIA, patients are referred to
John Veale’s low vision clinic for
further visual rehabilitation.
“I’ve developed a piece of
acetate with a clock on it. The
hands point in the direction
the patient needs to look, and
they can place it on their TV,
book or device at home and it
shows them where to look,” says
Veale who has been using these
methods for a number of years
in his free clinic, which is run in
conjunction with the Lighthouse
Vision Trust.
Combining his methods with
the MAIA machine, Veale says
he’s hoping to achieve faster
and more measurable results
with patients who can then be
accurately monitored.
The clinic at Southern Eye Specialists is
a fortnightly programme, taking place on
Friday afternoons in their current building.
As well as providing patients with expertise
Pacific hub in China, while the retail side is
housed at the Sydney Revesby Distribution
Centre. The centre has been in operation
since 2004. All employees at the centre will
be provided with outplacement services,
said the company and, where possible,
offered opportunities within Luxottica
business solution for our customers. We offer
a supply and fit programme which reduces
costs from the supply chain and helps
customers compete with bigger retailers.”
Through its parent company, VSP Global—a
US-based group of five complementary
businesses combining eye care insurance,
high-fashion eyewear, customised lenses,
ophthalmic technology and retail solutions—
GenOp is at the forefront of innovation in the
wearable market, says Saffin. “We are also
continuing to look at ways we can work with
optometry to increase the consumer’s focus
on the value of comprehensive eye care.
“General Optical has a lot to offer
independent optometry and is committed
to both the Australian and New Zealand
market. As the optometric landscape
continues to evolve, it’s important that we
work together as an industry to find creative
solutions. We’re looking forward to continuing
to work with our customers in New Zealand
as we further expand our support for them
and are enthusiastic about the future of eye
care in both New Zealand and Australia.”
GenOp’s brands include Airlock, Calvin
Klein, Chloe, Skaga, Salvatore Ferragamo,
Dragon, Jones New York, Bebe, Joseph
Abboud, Etnia, Pilgrim and Nike. ▀
and advice for how they can make the most
of their vision, Veale also provides living
skills assessments and guidance on low
vision aids. The clinic also supplies a number
of these aids to patients. ▀
Retail Australia.
“Over the coming months, a global team
will be working on the transition to supply
Luxottica inventories from our distribution
centre in China and will work with local
suppliers to maintain our highest standards
of service,” said Muir. ▀
www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand
For general enquiries, please email info@nzoptics.co.nz
For editorial and classifieds, please contact Jai Breitnauer, editor, on 022 424 9322 or editor@nzoptics.co.nz.
For advertising, marketing, the OIG and everything else, please contact Lesley Springall, publisher, on 027 445 3543 or lesley@
nzoptics.co.nz.
To submit artwork, or to query a graphic, please email lesley@nzoptics.co.nz.
NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11 times
a year, by New Zealand Optics 2015 Ltd. Copyright is held by NZ Optics 2015 Ltd. As well as the magazine and the website,
NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide that profiles the
products and services of the industry. NZ Optics is an independent publication and has no affiliation with any organisations. The
views expressed in this publication are not necessarily those of NZ Optics (2015) Ltd.
4 NEW ZEALAND OPTICS July 2016

©2016 NIKE, INC.
Become a stockist today
Toll Free 0800 141 444
generaloptical.co.nz
enquiries@genop.co.nz
July 2016
NEW ZEALAND OPTICS
5

First Kiwi DO Fellow
for European Academy
Gold medals for Kiwi
optometrist
Nicholas Black, a Kiwi dispensing optician
now living in the UK, is the first New
Zealander and only the fourth dispensing
optician to be made a Fellow of the European
Academy of Optometry and Optics (EAOO) as a
recognition of his services in low vision and contact
lenses.
He said it was a proud moment to be
acknowledged among his peers for the wide range
of services that can be provided as a dispensing
optician. “It acts to highlight our role and broaden
the potential for what we can do at a time when
the optometrist is taking on greater roles in the UK.
We need to be right alongside them offering our
support and taking on additional roles to expand
our presence, but also free them up so as a group we
deliver even better care and services.”
EAOO fellowship applicants have to apply
within four categories: Clinical Practice using case
records (up to five if solely case records); Research;
Education; and Professional Advancement and/or
Management of visual healthcare. Black submitted
a case record of a bioptic spectacle for a low
vision patient plus evidence of involvement in all
the other categories, including clinical research
within practice research on new contact lenses,
solutions and studies; education through delivery
of continuing education and training to peers and
colleagues at a practice, local and national level; and
professional advancement through local enhanced
service pathways for optometrists and dispensing
opticians and nationally through committees and
representation of the profession.
Nick Black (third from right) and other new EAOO fellows at the 2016 Berlin conference
“A significant number of fellows have been
predominantly academic in background, so it was
great to see more practitioners who spend most of
the day delivering at the coalface,” he said.
Black has an impressive optical pedigree from New
Zealand. He’s the grandson of Reg Black, founding
optometrist of Black Gates Meek & Dong in Lower
Hutt, son of retired dispensing optician Morris Black,
also from Lower Hutt, nephew of Eyeline Optical’s
Brian Black and cousin of Wellington optometrist
Andrew Black.
He attended Victoria University, worked with
Prolab in Wellington before moving to the UK
for his big OE, where he moved from laboratory
technician to DO, specialising in contact lens fitting
and low vision. He’s now a director-shareholder
and CEO of award-winning independent practice
BBR Optometry in Hereford, on the Welsh borders
in England, where he lives with his wife and three
children.
As to the future, he said, his practice has just had
a major refit so he’s busy reviewing how to improve
the business’ service and experience for patients
with his fellow directors and 20 staff, he continues
to provide specialist lens services at his local
hospital, including scleral and keratoconic lenses,
and he’s looking to take on a bigger role with the
Association of British Dispensing Opticians.
• Editor’s note: Congratulations Nick. Perhaps
we’ll be lucky enough to welcome you back
home one day to discuss how more DOs can
become involved in contact lenses and low
vision in New Zealand? ▀
Odette Smith celebrates an award winning lift in Hobart, Australia
When Odette Smith signed up for a
personal trainer at the gym three years
ago, she had no idea it would lead to an
international championship title and a couple of
gold medals to boot.
“I used to have a personal trainer every eight
weeks,” says Smith, an optometrist at OPSM
Queen Street in Auckland. “He got into Olympic
weightlifting and suggested I try it too.”
Smith found her small stature was an advantage—
the smaller you are, the less distance you have to
lift the bar—and was excited to find many other
women involved in the sport.
“I went to my first club competition at
Functional Strength Olympic Gym in Albany
about two years ago and met Richie Patterson, a
two-time Olympian and commonwealth games
medallist,” says Smith. “He coached a team of
mostly women and I decided to join.”
Smith competed first in regional competitions,
then national. The format is always the same—you
get three chances at the snatch, lifting the barbell
in one continuous motion from the floor to above
your head; and then three chances at the clean and
jerk, where the weightlifter raises the barbell to
their clavicle and then pushes it above their head
in a second movement. Results are calculated by
taking the two best scores from the lifts, taking into
consideration the lifter’s weight and age if over 35.
“My first international competition was in April
this year, the World Masters’ Cup in Tokyo,” says
Smith. “I was fine until I turned up at the Olympic
arena and saw them building the stage. Then I
freaked out!”
Smith recovered and not only held it together,
but went on to win the gold in the 58kg, 35-39 age
division.
At the start of June, she attended her second
international competition, the 2016 Olitek Oceania
and Australian Masters Championships and Pacific
Rim Tournament in Hobart, and picked up gold in
both competitions for the 53kg 35-39 age division.
“Since I started lifting two and a half years ago
I have set 24 New Zealand masters records. On 5
June I set a new New Zealand snatch record. I am
currently ranked number three in female masters
lifters in New Zealand, across all ages 35 plus and
weight categories.”
Smith also says that at 38, she’s in the best shape
she’s ever been and it’s never too late to take up a
new sport.
“There’s a woman at my gym who is a real
inspiration. She started weightlifting at 50 and now,
at 55, is in her best shape ever and is competing. The
weightlifting community is really supportive and
friendly, I love it.”
Smith is now training for the North Island
championships in October and the World Masters
Games, which will be held in Auckland in 2017.
We wish her luck! ▀
Transitions turns teacher
The 4 days of Optics
23 - 26 September 2016
LIVE THE EXPERIENCE
silmoparis.com
In the run up to spring and summer,
Transitions Optical’s new Australasian
marketing programme will focus
on educating consumers and eye care
professionals on the risks of harmful blue
light from the sun and from devices.
From July, eye care professionals
in New Zealand and Australia will
have access to educational materials
which explain sources of harmful
blue light indoors and outdoors, the
implications of prolonged exposure and
how Transitions lenses can provide a
measure of protection.
“Often associated exclusively with
electronic devices and screens, what
most people don’t realise is that
the sun is the single largest source
of harmful blue light, scattering it
through the atmosphere and emitting
significantly higher levels than
electronic devices and screens,” said
John Ligas, vice-president research and
development, Transitions Optical.
“In fact, depending on the time of day,
a majority of visible light outdoors is blue
light which explains why the sky is blue.”
All Transitions lenses filter harmful
blue light in all conditions, said the
company. Transitions Signature VII
lenses filter at least 20% of harmful
blue light indoors, up to two times
more than standard clear lenses,
and more than 85% outdoors when
Transitions Signature lenses filter harmful blue light indoors
activated. While Transitions XTRActive
filter at least 34% of harmful blue light
indoors and 88-95% outdoors.
The consumer education programme
will focus on the harmful effects of blue
light, building on Transitions’ Ready, Set,
Live, campaign which began in March
this year and has been seen by more
than six million consumers to date.
“We began 2016 talking to consumers
about the fact that better vision can
enhance their enjoyment of every day
life and their performance of activities
they love doing. Now we want to help
glasses wearers better understand
photochromic lenses, how they work
and the important health benefits they
provide beyond vision correction,” said
Stuart Cannon, Transitions Optical’s
general manager, Asia Pacific. ▀
6 NEW ZEALAND OPTICS July 2016

For the first time in Auckland,
Alcon brings you,
Sunday 31st July 2016
AUCKLAND 9.00am - 3.15pm
Interactive Workshops
UP TO 5 THERAPEUTIC CPD POINTS*
Please join the Academy for an interactive
workshop on Dry Eye management. Discuss
Dry Eye diagnosis and treatments with your
peers and witness live diagnosis by experts
in the field. Experience a hands-on approach
and get actively involved.
To register, please visit:
www.seeyouthere.com/dea2016nz
Or email:
eventrsvp@alconlabs.com
*application in progress
Alcon Laboratories (Australia) Pty Ltd, 109 Carlton Gore Road, Ground Floor, Newmarket, Auckland 1023,
New Zealand NZBN: 9429030206663. 106323SYS. NP4.A21604464718. TAPSPP7965
July 2016
NEW ZEALAND OPTICS
7

SPECIAL FEATURE: RANZCO NZ BRANCH SCIENTIFIC MEETING
Notes from the
lecture hall
From the chair
BY DR STEPHEN NG, RANZCO NZ EXECUTIVE CHAIRMAN
The Dunedin Annual Scientific Meeting of
the New Zealand Branch of RANZCO was a
great success on many fronts. It was well
attended by both ophthalmologists and registrars
from throughout the country. In addition, there
was a full programme and very good attendance
at the parallel Ophthalmic Nurses’ Conference.
I was impressed that the convenors had invited
three very impressive keynote speakers: Professor
Andrew Lotery from Portsmouth, Professor Glen
Gole from Brisbane and Dr Mark Chehade from
Adelaide. For me, the highlight of the conference
was the breadth and depth of their presentations
on “cutting edge” topics in ophthalmology. For
example, Professor Lotery’s talk on the genetic
factors in age-related macular degeneration
linked two subjects that will be the prime areas
of research in ophthalmology. Professor Gole’s
presentations on treatment of amblyopia and
progressive myopia in children referenced an
evidence base which has not previously been
available in paediatric ophthalmology. While Dr
Chehade’s presentation on strategies to overcome
workforce issues is very pertinent in New Zealand
and generated brisk discussion from the audience.
The New Zealand Branch of RANZCO’s Annual
Scientific Meeting is also an important forum for
updating fellows and trainees on College issues.
RANZCO increasingly is undertaking an advocacy
role on issues that affect our patients. Two current
issues for the New Zealand Branch of RANZCO
are the “Choosing Wisely” campaign, that aims to
establish guidelines for our profession and allied
professions to highlight wasteful, ineffective
procedures and investigations; and secondly,
the New Zealand Branch of RANZCO is planning
a campaign to highlight the impact on patients
who are not being seen in a timely fashion for
follow-up care in public hospital ophthalmology
departments.
On behalf of all attendees, I wish to thank the
convenors of the conference; Drs Mary-Jane Sime,
Logan Mitchell and Casey Ung, for all their hard
work and tremendous hospitality.
Finally, I look forward to seeing as many of you
as possible at the 2017 New Zealand Branch
RANZCO Annual Scientific Meeting in Paihia on
12 - 13 May 2017.
Regards
Stephen
BY SAMANTHA SIMKIN*
The New Zealand Annual Branch Meeting
of the Royal Australian and New Zealand
College of Ophthalmologists (RANZCO)
convened in the Dunedin Town Hall on a crisp,
clear Otago day. The leaves were beginning to
change in The Octagon and the bracing air awoke
the senses. The strength and beauty of the Victorian
buildings evoked the scholarly mind as delegates
from near and far, North and South New Zealand
and overseas gathered together.
A wonderful two-day scientific programme was
organised for the ophthalmologists for which the
convenors, Drs Logan Mitchell, Mary Jane Sime and
Casey Ung, expressed their gratitude to Professor
Charles McGhee for his input and guidance.
Concurrent programmes for ophthalmic nurses
and ophthalmic technicians were also held in the
Dunedin Town Hall.
We were welcomed into the warm and inviting
Glenroy Auditorium for the 2016 meeting, themed
The developing eye, developing techniques and
developing therapies, by New Zealand Branch chair
Dr Stephen Ng.
To cover this interesting and broad topic base
three keynote speakers were invited: Professor
Andrew Lotery, professor of ophthalmology in
medicine at the University of Southampton,
a clinician scientist who works from bench to
bedside on common causes of blindness including
age-related macular degeneration and glaucoma;
Professor Glen Gole, director of ophthalmology at
the Lady Cilento Children’s Hospital and Children’s
Health Queensland, who has special interests
in retinopathy of prematurity, vision screening
and paediatric low vision; and Dr Mark Chehade,
Samantha Simkin, Naz Raoaf with Drs Shuan Dai and Stuart Carroll
principal ophthalmologist at the North Adelaide
Eye Centre and director of the Cornea and External
Disease Unit of the Royal Adelaide Hospital.
Developing eyes: ROP and amblyopia
Paediatric ophthalmology had a wonderful platform
at this general ophthalmology meeting, with the
importance of paediatric eye care being highlighted
in a number of sessions.
Professor Glen Gole was the first of many speakers
to discuss retinopathy of prematurity (ROP) with the
inquisitive title, ROP – is it all Retcam and Avastin
from now on? He discussed the new developments
and compared them to current practice, expressing
the need to develop whilst maintaining standards
with the epidemic of ROP particularly in middle
income countries.
Dr Malcolm Battin, clinical director of neonatology
at Auckland District Health Board followed Glen
Gole’s comprehensive ROP review. Dr Battin
brought a different and eye opening perspective
of the neonate as a whole, reminding us they aim
for quality of outcome as well as survival in these
vulnerable infants.
CONTINUED ON P10
RANZCO NZ chairman Dr Stephen Ng presents Dr Peiyun Wang with the
award for Best Scientific Presentation by a junior ophthalmologist
Dr Shaun Dai, Samantha Simkin, Professor Glen Gole and Dr Malcolm
Battin
Toomac’s Mark Taylor and Ian MacFarlane
Ros Pearce, Nina Molteno and Professor Anthony Molteno
- Perfect 3 dimensional control of
every intravitreal injection
Walieka Barlon, Jenny Ryan and Carol Slight
- Single handed sharps safety
- The only intravitreal injection system
compliant with international legislation
on the use of sharp safe devices
- Streamlined workflow
Jan Chai and Lumenis’ Brock Flowers
is now available in procedure packs
Contact Toomac Ophthalmics for a demonstration mark@toomac.co.nz
info@salarsurgical.co.uk
Dr Logan Robinson with Chris Money and Mark Thorndyke from Zeiss
8 NEW ZEALAND OPTICS July 2016

It’s all in
You make every move with the
utmost care and consideration.
Shouldn’t you choose your
phacoemulsification system
that way too?
How do you phaco?
WHITESTAR SIGNATURE is a trademark owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. Australia: Abbott Medical Optics, 299 Lane Cove Road, Macquarie Park, NSW 2113, Australia.
New Zealand: Abbott Medical Optics (AMO Australia Pty Ltd) PO Box 401, Shortland Street, Auckland, 1140. ©2016 Abbott Medical Optics Inc. | www.AbbottMedicalOptics.com July | PP2016CT0711 NEW ZEALAND | WH20283 OPTICS
9

SPECIAL FEATURE: RANZCO NZ BRANCH SCIENTIFIC MEETING
Convenor Dr Logan Mitchell (right) thanks keynote Dr Mark Chehade
CONTINUED FROM P8
Dr Shuan Dai, a consultant ophthalmologist with
Eye Doctors and Greenlane Hospital in Auckland,
presented the new New Zealand guidelines for
the screening and treatment of ROP, while Dr
Justin Mora, a consultant ophthalmologist with
Eye Doctors and Greenlane Hospital in Auckland,
shared the results of the International Paediatric
Ophthalmology and Strabismus Council survey of
worldwide trends in ROP. Dr Mora’s presentation
showed the alarming trend of ROP growing in
middle income countries and the concern that this
same trend could occur in lower income countries as
their neonatal care improves.
As ROP is almost always a preventable cause of
blindness, it was encouraging to see the work going
on both nationally and internationally.
Amblyopia was also well covered, firstly by
Professor Gole and then Dr Ben Thompson, adjunct
professor at the Department of Ophthalmology at
McGill University, who Skyped in from Canada for
his session.
Dr Thompson presented on novel binocular
treatments for amblyopia including a modified
tetris game and non-invasive brain stimulation.
Encouragingly randomised control trials with the
tetris game have begun as a possible treatment
for amblyopia. The neuro-scientific basis of his
presentation challenged us to think of why and
how we treat as we do. An extremely interesting
body of work presented beautifully from the other
side of the world.
Professor Gole wrapped up his keynote
presentations on the developing eye with
conversation on the appropriate correction of
childhood refractive errors. He emphasised
the need to cycloplege all children for accurate
refraction, the importance of dynamic retinoscopy
for near prescribing and the worrying increase
in myopia worldwide. Professor Gole shared his
solution to this workforce issue, the Paediatric
Optometry Alignment Pilot Project. Optometrists
interested in paediatrics could be up-skilled
and become allied providers. The alignment
project brings unity between optometry and
ophthalmology, aids patients to transition
smoothly from diagnosis to glasses and
maximises the workforce skills available. The
presentation was honest, to the point, and driven
with a passion for seeing patients looked after.
Developing techniques
Developing techniques is often what draws us all
together at conference, the desire to do more for
our patients, to achieve better, to fix more and
thus, many great talks fell into this category.
Ophthalmic imaging is core to ophthalmic
Janette McLeod showing Allergan’s new app
practice. Dr David Squirrell, from Greenlane
Hospital in Auckland and Milford Eye Clinic,
presented a fascinating review of the importance
of choroid imaging, questioning the role
of the choroid in chronic macular disease
pathophysiology. It was an enlightened talk that
made many people stop and think about their
practice and understanding of “everyday diseases”
such as age-related macular degeneration.
Dr Chehade, our keynote speaker from Adelaide,
and Dr Brian Kent-Smith, from Eye Specialists
Whangarei and Northland DHB, discussed
developing techniques for workforce management.
Dr Chehade shared his insights and queries of
what the future of ophthalmology will look like.
This included electronic health records, medical
scribes, increasing patient load and decreasing
funds, which all combined to give an emotive
and topical presentation that kept many people
talking afterwards, both privately and in open
discussion in the large auditorium. Dr Kent-
Smith talked about his personal experience of
upskilling nursing staff. His technique was to
offer varying, interesting roles to nurses allowing
them to rotate through theatre, clinic and pre/
post-op in any given week. Team morale and
job satisfaction results in better outcomes for
patients, consistency for surgeons—due to less
staff turnover—and a nicer work environment.
Two great talks on a topic that affects us all.
Many more interesting techniques were
discussed throughout the conference. Dr Jo
Sims, of Auckland Eye and Greenlane Hospital
in Auckland, gave an interesting talk titled
Something old, something new, something
borrowed, something blue. The take-home
information was the astounding new data of
gut microbe effects on our overall health and
thus eye conditions. The developing technique
of nanosecond laser for age-related macular
degeneration treatment was presented Dr David
Worsley of Hamilton Eye Clinic, who shared his
experience and specific technique.
Developing treatments: from lab to clinic
Talk of new treatments always causes the ears to
prick and the heart to patter; the idea of making
the blind see is an inspiration for many of us, and
RANZCO Dunedin was littered with lectures that
made this inspiration seem a lot closer.
Professor Lotery described how ophthalmology
is at the forefront in genetics because
ophthalmologists are great phenotypers and
“good phenotyping allows for good genotyping”.
However, just finding the genes is not enough.
The development of gene therapy for genetic
conditions is needed. Professor Lotery then went on
to inspire the audience with the story of Lancelot, a
Briard sheep dog with Leber’s congenital amaurosis
(LCA), who following a single treatment of gene
therapy in one eye was able to see and continues
to see. This same treatment for LCA is continuing to
Phase III clinical trials in humans. Professor Lotery
also left us with the question, “but what about the
‘common’ folk?”; those diseases that affect a large
number of people coming through our clinics, such
as age-related macular degeneration (AMD), could
gene therapy be the answer?
AMD had a further spotlight with Dr Andrew
Thompson from Tauranga Eye Specialists
presenting his research into the availability of
Avastin throughout New Zealand. Disparity in
availability was noted even when population
demographics were taken into account. The
presentation was met with lively discussion
and debate, summed up by Dr Thompson thus:
“to reach a desirable future where all who need
treatment have access, three things are required:
a national planning strategy, adequate funding
and patient advocacy for change.”
Professor Lotery returned on Saturday morning
to again excite the delegates with interesting
new treatments. This time he was talking
about non-neovascular macular diseases and
pharmacological treatments. Fascinating results
were presented for eplerenone for central serous
retinopathy and lampalizumab for geographic
atrophy. Ongoing clinical trials are underway, so
watch this space.
Personal highlights
There are always sessions at conference that stay
in your memory. For me, there were two this year.
Firstly, the eloquent and entertaining Gordon
Sanderson, associate professor, ophthalmology at
the University of Otago, who presented his journey
through 40-plus years of ophthalmic teaching.
This was a light-hearted, memory-filled journey
of Gordon’s experience from first arriving in New
Zealand to the present day. Photos accompanied
his wonderful anecdotes with many familiar
faces popping up along the way, many capturing
members of the audiences’ much younger selves!
Through the hilarity some pearls of wisdom were
included: undergraduates need to be entertained to
keep their focus; students and registrars appreciate
your interest in them as people; and registrars need
to know how to refract.
My second highlight was the rapid fire/free
paper session. Presenters included registrars, an
optometrist, ophthalmologists and a public health
physician. Topics ranged from bench to bedside
and everywhere in between. Health economics,
surgical and clinical techniques, atropine and SLT
treatment, imaging and thought-provoking case
reports. The standard of presentations was high
with well-considered and inquisitive questions from
the floor to both aid and guide research endeavours
in the future. The collegial support of the junior
presenters was felt by all.
Developing friendships
Although there was a plethora of interesting
content and discussion at RANZCO there was also
a great social atmosphere where friendships, old
and new, were developed and rekindled. The Friday
evening welcome function was held in the main
hall of The Dunedin Centre amongst the exhibitors.
Drinks, nibbles, the largest pipe organ in New
Zealand and a beautiful acapella group added to
the warm and friendly atmosphere. While on the
Saturday evening conference attendees were given
a real treat at the conference dinner. The Toitu
Otago Settlers Museum was lit up as we arrived
for drinks and then, when it was time for dinner,
we were able to meander through the stunning
displays of vehicles, outfits and images depicting
the life and times of the Otago region. We were
then entertained by a Lion Dance from the Otago
Southland Chinese Association, featuring Dr
Casey Ung’s own children, and were treated to a
wonderful, thought-provoking presentation from
“that blind woman” Julie Woods, a Dunedin local
who is challenging the perception of blind people
worldwide. Mix that with delicious food, great
company and dancing and it was a wonderful
evening.
In summary Dunedin RANZCO 2016 was a
collegial, interesting, and thought-provoking
event. A conference that fed our brains, bellies
and friendships. I can’t wait for the next one. ▀
* Samantha Simkin is a therapeutically qualified optometrist
from the University of Auckland. She is currently pursuing
her PhD in the Department of Ophthalmology with a focus
on visual impairment in children. Samantha is supervised by
Professor Charles McGhee and Drs Shuan Dai and Stuti Misra
Dr Alastair Papali’i-Curtin, Samantha Simkin and Dr Ammar Binsadiq
Drs Muhammed Kahlid, Casey Ung and John Ah-Chan
Drs Kevin Taylor and Peter Haddard
Dr Paul Cohen, Tricia MacDonald and Chris Williamson
Niamh Kelly, Sally-Anne Herring and Libby Kelly
Drs Shenton Chew and David Worsley
Drs Chee-Foong Chong and Mike O’Rourke with Chantal O’Rourke and
Drs Mark Donaldson and Sid Ogra
THEME: NGA TANIWHA TIGERS AND TRAPS: Avoiding
problems and acquiring sub-speciality pearls in ophthalmology
New Zealand Branch
Annual Scientific Meeting
Friday 12 and Saturday 13 May 2017
Copthorne Hotel Bay of Islands, Paihia
Incorporating the New Zealand Ophthalmic Nurses’ Group Meeting,
New Zealand Orthoptists’ Society Meeting and
Practice Managers‘ Meeting
www.ranzco2017.co.nz
T H E L E A D E R S I N E Y E C A R E
Blackmore’s Nicole Jellard, Drs Dianne Sharp and Ian Eilliott and Phillippa Pitcher from MDNZ
10 NEW ZEALAND OPTICS July 2016

A nurse’s
perspective
What’s new: from the exhibitors’ hall
BY RACHEL COOK*
An acapella group entertains in the Dunedin Town Hall
Dr Sheng Chiong Hong and Rachel Cook
Dunedin was a chilly destination for this
year’s RANZCO conference, but I felt
warmed by the wonderful atmosphere
and the opportunity to meet with fellow
colleagues. The topics and presenters were varied,
my only regret was that by skipping between the
specialist and nurse sessions you were bound to
miss out on something!
Great information was presented on patient
pathways, ranging from intraocular tumours to
eye prosthetics. This included some very personal
insights from presenters into the journey
patients travel. Also interesting were the talks
emphasising the benefits of teamwork and open
communication in the workplace—something we
all know, but perhaps need to make more
time for.
In particular, I enjoyed hearing from our clinical
nurse specialists on interesting cases they have
encountered in their practices. Kathryn Lee, from
the Auckland District Health Board (ADHB), shed
light on the more uncommon side of floppy
eyelid syndrome, while Waikato District Health
Board’s Lynn Scott discussed the rare serpiginous
chorioretinitis. It was not just the syndromes that
held my interest, but the way nursing practice
can have such a positive impact on a patient’s
perception of their healthcare.
It was great also to hear from Jennifer Mor, a
tutor with the Fred Hollows Foundation in Papua
New Guinea, and Artika Avikashni from Fiji about
the challenges they face in their daily nursing
practice.
Clinical nurse specialist Carol Slight from ADHB
provided valuable information on standing order
requirements—I wonder how many of us would
love to access ADHB’s online “moodle” site to sit
the competency modules?
The real highlight for me this year, however,
was “that blind woman,” motivational speaker
Julie Woods, who was the guest speaker at
the conference dinner on the Saturday night.
She provided insight into her life since her
30s when, as a mother of two small children
she was registered as blind. Her speech was
inspiring as she related how she maintained
her independence and learnt to step out of her
comfort zones by saying “yes” to any opportunity
and experience, despite the worry of wondering
whether there would be a railing at the top of the
Eiffel tower! An honest and real ambassador for
what we are all here for. It was humbling to hear
her story.
In line with saying “yes”, I also put myself
forward this year to present with Dr Sheng Hong
on how the ODocs EyeCare smartphone system
has been used to enhance nursing practice in the
small town of Gisborne. Perhaps some of you will
also put yourself and your experiences out there
at the next conference. It’s a rewarding challenge,
as we learn so much from the diversity of each
other’s experiences, of our challenges and our
triumphs.
Roll on RANZCO 2017! ▀
* Rachel Cook is an ophthalmology speciality nurse at the Eye
Clinic at Gisborne Hospital
The grand baroque style of The Dunedin
Town Hall with its imposing, floor to ceiling
1919 symphonic organ, provided a stunning
backdrop to the exhibition portion of the 2016
New Zealand Branch of RANZCO’s Annual Scientific
Meeting. The event was well supported with 19
exhibitors, including three major sponsors: Abbott
Medical Optics, Alcon and Toomac Ophthalmic.
The atmosphere was both warm and busy, with
some cleverly-staged timing by the exhibition
organisers—staggering the break times of the
main scientific programme and the concurrent
ophthalmic nurses and technicians programmes—
ensuring exhibitors weren’t too overrun during the
breaks.
The following are some of the highlights from the
exhibitors’ hall.
Abbott Medial Optics
Abbott was showcasing two key products, the
Signature Pro Phaco machine, which was launched
in April, and the Symphony extended range vision
lens. Abbott offer a full range of IOLs, including
an extended range option, which is different from
a multifocal as it offers a continuous focus with
no blurring. The compnay has developed this lens
in-house and it is unique technology, said Henri
Buhagiar, Abbott’s Australasian phaco specialist.
Toomac Ophthalmic
Toomac introduced the new SP.eye Intravitreal
Injection System from Salar Surgical. The first such
device of its kind, the SP.eye reportedly reduces the
steps in the intravitreal workflow, by combining
precise needle positioning with sharps safety.
“It’s easy and safe, compared to any other
system, said Toomac director Ian MacFarlane. “It
was born out of necessity and developed by an
ophthalmologist in the UK.”
The device was lauded in the UK journal The
Ophthalmologist in December 2014 as one of
the top ten best innovations of the year and will
become increasingly important as procedures
become more nurse-led, said MacFarlane, adding
there was a lot of interest in the new product at the
meeting. “We only introduced it a month ago and
we’re delighted with the response so far. It allows
for precise measurement, proper angle and depth of
injection: simplicity can’t get better.”
New Zealand’s also first to get the device over
Australia, though Toomac is considering taking it
over there later this year.
New Zealand’s also first to get the device over
Drs Antony Suter and Michael Merriman
Drs Mike Mair and Rod Keillor
Australia, though Toomac is considering taking it
over there later this year.
Also attracting interest on Toomac’s stand was
the Haag Streit Octopus 600 Perimeter with Pulsar
Technology. Pulsar offers a very fast, one-minute
screening test that is designed to be highly sensitive
and specific to detect glaucoma and allows full
follow-up with white on white on the same device.
Molteno Ophthalmic
Despite being around for more than 30 years,
this was the first time Kiwi company Molteno
Ophthalmic has ever taken its own stand at a
conference, marking a new and exciting direction
for the glaucoma implant firm, says equally new
chief executive Dr Nina Molteno.
Dr Molteno, a former GP and daughter of wellknown
Kiwi ophthalmologist Professor Anthony
Molteno, whose ground-breaking research resulted
in the purpose-built implants now being marketed
by the company, said for the last 30 years the
product had pretty much been marketed by wordof-mouth
alone. “We have a really solid reputation
and a great product, but we realised we needed
to tell people about ourselves so they can take
advantage of it.”
Produced in a purpose-built facility in Dunedin,
Molteno implants are used across the world, but
424
still far too few people know about them, said Dr
Molteno. “We have the longest clinical trials of
any implants and that and our understanding of
what makes glaucoma surgery work has informed
the design of our new implants, so we have a lot
to talk about.”
Lumenis
Attracting interest on Lumenis’ stand was its
M22 with Optimal Pulse Technology, the next
generation of Intense Pulse Light (IPL) technology,
for treating dry eye disease and rosacea, and its
Selecta Trio, a three-in-one laser product offering
NOW AVAILABLE IN NEW ZEALAND
THE ARTIFICIAL IRIS
Regardless of partial or complete aniridia – the world’s first artificial iris prothesis
provides a solution to restore vision not only optically but also aesthetically,
and is now available in New Zealand from Spectrum Surgical
032
Thomas Cook, Josie Fletcher and Marcus Ebert
Spectrum Surgical specialises in the sale of leading edge surgical and medical devices to
health care professionals and hospitals. We offer innovative and ground-breaking solutions
from companies of the highest quality, providing our clients with advancements in
ophthalmic surgery, diagnostics and more.
NB: Spectrum Surgical is the new distributor of FCI products, leading manufacuturer of: bicanalicular and
monocanalicular intubation, punctum plugs, ptosis slings, orbital implants, purified silicone oils, perfluorocarbon
liquids, disposable vitrectomy lenses, scleral buckles and intravitreal assistants.
For more visit http://www.spectrumsurgical.com.au/ or contact: Peter Grech, managing director,
at pgrech@spectrumsurgical.com.au or +61 3 9562 2472
CONTINUED ON P11
July 2016
NEW ZEALAND OPTICS
11

SPECIAL FEATURE: RANZCO NZ BRANCH SCIENTIFIC MEETING
CONTINUED FROM P11
retinal, cataract and advanced glaucoma therapies
in a single platform.
The company was formed in 2003 from the merger
of Coherent Medical Group, ESC Medical Systems
and HGM Medical Laser Systems—companies
best known for pioneering the first argon laser
photocoagulator; Nd:YAG photodisruptor lasers;
and SLT technology for managing POAG—but only
set up a direct sales, service and support role in
Australasia last year.
Headquartered in Israel, Lumenis is focused on
providing “minimally-invasive clinical solutions
for the surgical, ophthalmology and aesthetic
markets,” specifically developing innovative
energy-based technologies, including laser, IPL
and Radio-Frequency (RF).
OptiMed
Attracting particular interest on the OptiMed
stand was the PanoCam LT, a new product on
the market for paediatric digital imaging. The
device provides 130° field of view for imaging
ROP, retinoblastoma and other retinal disorders.
Importantly, said OptiMed’s Craig Norman, the
image capturing unit is not tethered to the
console allowing for image capture anywhere, in
the hospital or offices, allowing easy access to the
patient and remote diagnoses.
Another product capturing delegates’ interest
on OptiMed’s stand was the Optos California,
Optos’ latest ultra-widefield (UWF) imaging device
designed specifically for vitreo-retinal specialists
and ophthalmologists. According to the product
information, the California includes a new UWF
optomap imaging modality, indocyanine green
angiography as well as composite colour, red-free,
autofluorescence and fluorescein angiography.
Spectrum Surgical
A fascinating product attracting a lot of interest
on the Spectrum Surgical stand was the
company’s artificial iris, a German-made, siliconebased
prosthetic that is tactile and can be made
so they are indistinguishable from the patient’s
other iris or part-iris.
Though there are other products on the market
designed to stop light and replace a patient’s
damaged iris, this is the only one on the market
that is designed to be as cosmetically-pleasing as
it is effective, said Spectrum Surgical’s Peter Grech,
adding there are already a handful of patients in
New Zealand happily sporting their new irises.
Other products attracting interest on the stand
were Spectrum Surgical’s Torica range from
HumanOptics, one of the first manufacturers to
have produced toric IOLs and one of the few that
produces special designs for extraordinary power
ranges requiring high cylinders, up to 30.0 D,
whether it be for the capsular bag or ciliary sulcus;
plus an array of oculoplastic and vitreoretinal
products from the Paris-based ophthalmic surgical
device company FCI such as Painless puctum plugs,
Mini-Monoka, Nunchaku, the StopLoss Jones tube
system, orbital implants, vitrectomy lenses and the
Invitria, an intravitreal injection assistant device.
Alcon
With the biggest surgical portfolio in the Southern
Hemisphere, the company claims, Alcon continues
to offer a complete product range from capital
equipment to surgical consumables. Their big
launches this year are in the IOL space, with their
new Panoptix trifocal lens and Ultrasert, the preloaded
IOL delivery system.
Allergan
Allergan introduced a new app for glaucoma
patients at the meeting. Developed in tandem
with researchers at City University in London for
newly-diagnosed glaucoma patients, the free
app covers topics such as why eye pressure is
important and the correct use of eye drops. It
even allows users to experience the impact of
glaucoma on everyday situations such as driving,
cooking, walking down the stairs or shopping.
“It means doctors have information they can
give patients and the patients families, that they
can download and look at in their own time…
as patients simply can’t take it all in in one
session at a doctor’s,” said Allergan’s senior brand
manager ANZ Janette McLeod
Device Technologies
Device Technologies’ stand had a plethora of
high-tech, internationally sourced products. Its
Oculentis implants, including extended depth
of focus IOLs, continue to impress patients who
receive these, said product specialist Diego
Sonderegger, while the company’s new posterior
and anterior Swept Source OCT, the Topcon Triton,
impressed delegates with its high resolution
scans and OCT angiography capabilities. The
company was also showing it’s “very easy to use”
Quantel micropulsed yellow pattern laser.
Corneal Lens Corporation (CLC)
CLC was exhibiting its Thera Tears dry eye product
range and it’s MacuShield nutritional products for
AMD and general eye health.
The Thera Tears range is a comprehensive range
for dry eyes and blepharitis, providing an omega
3 supplement to help eyes, lids and tear film
function at their best, and a preservative-free
lubricating eye drop for dry eye sufferers and
patients after surgery.
Designs for Vision
The flagship offering from Designs for Vision
is the upgraded iCare tonometer, the ic100,
which recently won a Red Dot design award
and an iF design award. This lightweight, hand
held tonometer offers accurate and reliable
eye pressure measurements in a few seconds,
with no need for anaesthetic and without the
discomfort of the air puff method. The upgraded
iCare features new alignment assistance and
ergonomic design. It works by using a probe so
light and gentle, the patient can hardly even feel
it. It was only released a few months ago, and
Designs for Vision is the official supplier for New
Zealand and Australia.
Ophthalmic Instrument Company
OIC had a busy RANZCO demonstrating the new
range of ophthalmic ultrasounds from Sonomed,
including the Vu-Max Combined UBM & A/B
Scan and the Vu-Pad tablet based A/B Scan. The
new Clear-Scan attachment for the UBM probe
encases the end of the probe in a self-contained
water bath allowing the UBM to be used without
the patient lying supine and without the
traditional mess of a water bath. The Vu-Max was
commissioned at Dunedin Hospital in the days
following RANZCO.
Also generating a lot of interest was the Nidek
Robert Nyenkamp, Dr Justin Mora and Richard Maton
The band at RANZCO 2016
RS-330 Duo Combined Retinal Camera and OCT
and the latest generation of hand held auto
refractor/keratometer the Nidek HandyRefK.
Among the new surgical products from OIC, the
MST Duet Handle with single use packer/Chang
IOL cutting kits continue to grow in popularity.
They easily cut the hardest of foldable acrylic
lenses and also come in reuseable form.
Zeiss
A lively stand, surgical products specialist Mark
Thorndyke was keen to talk visitors through Zeiss’
flagship microscope, the Lumera 700. Released
to the market four years ago, it has enjoyed a
recent update – the integration of the Callisto Eye
markerless toric alignment and patient platform
– a giant screen to aid the surgeon. The advanced
technology of the toric alignment tool means you
no longer have to hand mark the eye, ensuring
accuracy and improved workflow, said Thorndyke.
The addition of the IOL Master 700 Biometer
and the Zeiss range of IOLs, makes up the ZEISS
Drs Graham Wilson, Nina Ashroff and Graham Reeves
Peter Stewart from AFT
Cataract Suite, a fully networkable group of
products to allow seamless transition from
biomentry to implantation, he added.
Bausch + Lomb
Radiant Health, the local distributor for Bausch +
Lomb, had its full range of IOL’s on show, including
its FineVision Toric lens, a tri-focal that has only been
available in New Zealand for 18 months.
AFT Pharmaceuticals
AFT’s Peter Stewart was highlighting the Kiwiborn
pharmaceutical company’s preservativefree
HYLO-Fresh and HYLO-Forte eye drops, both
compatible with contact lenses, and VitA-POS eye
ointment. VitA-POS is designed for dry eye sufferers
to keep their eyes lubricated during the night by
preventing evaporation from the ocular surface.
The Scientific Meeting is a great chance to meet
the ophthalmologists and ophthalmic nurses to
talk about how the products can help patients both
during and after surgery, he said. ▀
Last RANZCO for McIver
Spectrum Surgical’s Peter Grech with Cameron McIver and Dr Jim Borthwick
RANZCO NZ 2016 was the
last RANZCO meeting for
Cameron McIver, who used
the opportunity to tell those who
didn’t know, that he was retiring
from his position as New Zealand
branch policy advisor.
Appointed to the role in 2011,
McIver was considered a much
needed presence for the College
in Wellington at that time. He has
a long history working for and
advising the health services in New
Zealand, including as CEO of the
New Zealand Medical Association
from 1995 to 2011.
At RANZCO, McIver said he was
looking forward to taking a few
voluntary positions to ease his way
into retirement.
There are no plans to replace him
in New Zealand. ▀
Ophthalmology in Japan
28 Feb - 11 March 2017
Tour leader Professor Christopher Liu
www.jonbainestours.co.uk/ophthal
Optometry in Peru
2 - 14 April 2017
Tour leader David Shannon
www.jonbainestours.co.uk/optometry
Jon Baines study tours are fully escorted and combine a
rich cultural itinerary with a series of professional visits.
For a brochure, please contact us on:
info@jonbainestours.com.au
or call: 03 9343 6367
www.jonbainestours.com
12 NEW ZEALAND OPTICS July 2016

The wider world of
medicine and optometry
If quick-fire presentations, good food and great
wine are your thing, then the Eye Institute’s
education seminar on 24 May certainly
delivered. With more than 145 attendees and eight
speakers, the evening was a lively start to the Eye
Institute’s annual seminar series. The focus of the
first meeting was on applying evidence-based
medicine to everyday optometry practice.
Optometry and GPs
Dr Shanu Subbiah, who recently welcomed
his second child into the world, took the stage
first with a look at the relationship between
optometry and general practice. Does your
patient’s GP need to be involved in their eye
care? When is it prudent to get them involved?
And what role should they take? These were all
questions Dr Subbiah addressed, reassuring the
audience that patient care is teamwork, and the
GP often plays a central role as the conductor,
curating the flow of information. “Many
ophthalmic diseases can have underlying systemic
pathology,” he said. “Often these conditions can
be treated more effectively by the GP.”
His presentation provided a summary of systemic
conditions to watch out for, such as macular
degeneration, when early referral to the GP is
essential to optimise patient care within the
multidisciplinary team.
Five scary things and the optic nerve
Professor Helen Danesh-Meyer stepped up next
to talk us through “five scary things” in relation to
the optic nerve. Using a series of images, Professor
Danesh-Meyer challenged the audience to identify
the nerve problem. She focused on signs of optic
nerve head morphology to assist in determining
the underlying cause of the optic nerve disease
and the appropriate management strategy. Key
takeaways included the need to run visual field
tests, to take care to focus on the rim and to
remember that all patients will have different size
eyes naturally.
Zika virus update
Dr Peter Ring gave us an interesting update on the
Zika virus, which was first identified in 1947 in the
Zika forest in Uganda. Since 2007, Zika has become
a common word in our language as outbreaks
of the once rare virus continue to occur globally.
Symptoms include rash, fever, achy joints and nonpurulent
conjunctivitis. They can often be mistaken
for other, more benign illnesses and the symptoms
resolve within seven days but can lead to Guillain–
Barré syndrome (in rare cases) and microcephaly
in infants when a mother becomes infected
during pregnancy. There is a third complication for
optometrists and ophthalmologists to be aware
of and that is chorioretinal atrophy and optic
nerve abnormalities. Studies are currently being
undertaken, using blood extracted from infants
with microcephaly and chorioretinal atrophy, to
establish the link.
Cross-linking shared care
Dr Adam Watson’s topic was cross-linking (CXL),
which usually involves removal of a broad area
of corneal epithelium followed by application of
riboflavin and ultraviolet light energy. “Shared care
of patients following CXL is common,” he said. “It
is important that the optometrist is aware of the
normal course of healing, what topical medications
are typically used and why, and potential
complications including microbial keratitis and
atypical inflammatory responses requiring specific
treatment.”
Dr Watson also talked us through post-treatment
care and atypical outcomes to be aware of.
Lens regeneration research
After the break, Dr Trevor Gray welcomed us back
and reviewed recent amazing research published
in Nature around lens stem cell regeneration of
the phakic lens in paediatric cataract patients. The
research team in China removed the lens of several
infants born with cataracts and demonstrated
how over a matter of weeks the eye began to bring
forward lens epithelial stem cells. By five months,
post op, the infants had generated a new, clear,
biconvex lens (see story on p3 and column
this page.)
Retina condition quiz
In a fun, high-speed session Dr Peter Hadden
presented the audience with a series of slides and
asked them to identify the condition. He then
talked about the treatment, care and management
Drs Peter Hadden and Trevor Gray
Speakers Dr Simon Dean and Dr Shanu Subbiah
Dr Peter Hadden and Michael Holmes
Kevin Wong and Shelly Brannigan
of each vitreoretinal disease that was identified.
Laser eye surgery post-op management
As iLASIK laser eye surgery becomes increasingly
more common, Dr Nick Mantell used his talk to
address what is normal post-surgery and what
changes/symptoms need to be addressed. “Comanagement
optometrists for our out-of-town
patients play a vital role in monitoring iLASIK
patients. We are not only interested in the refractive
outcome but also the appearance of the LASIK flap.
The appearance of the flap post-operatively can be
quite variable and it can be difficult to differentiate
what is normal and what is abnormal.”
Dr Mantell explained how the flap should look,
when to refer back and when abnormal findings
are clinically insignificant.
Pterygia and pingueculae
The evening was rounded up nicely by Dr Simon
Dean, who looked at the conditions pterygia and
pingueculae, their therapeutic management and
when surgical intervention is necessary. “The
assessment of how to intervene in management
of these ocular surface irregularities takes into
account a number of factors,” he said. “A simple
framework of whether they are vision threatening,
significantly uncomfortable, cosmetically
unacceptable (or frequently a combination of the
above) will help to decide the best management.”
Dr Dean noted continued assessment at regular
intervals can also help alter the management over
time. “These masses can change and grow requiring
an escalation of intervention and there is always
an index of suspicion regarding ocular surface
squamous neoplasia making follow-up prudent.”
The next Eye Institute evening education seminar
will be held on 16 August. ▀
Focus on
Eye Research
Retinopathy, stem cell
regeneration and myopia in
Europeans
MORIN, J. ET AL. NEURODEVELOPMENTAL
OUTCOMES FOLLOWING BEVACIZUMAB
INJECTIONS FOR RETINOPATHY OF PREMATURITY.
Pediatrics 2016;137(4)
Review: The appeal of intravitreal bevacizumab for
the treatment of ROP is obvious – to use a small
injection of intraocular anti-VEGF agent to treat a
baby-blinding disease explicitly caused by VEGF.
The BEAT-ROP study, among others, has shown the
effectiveness of intravitreal bevacizumab in treating
ROP with ‘plus’-disease. However, concerns about
the long-term sequalae of anti-VEGF treatment in a
developing child abound, but relevant high-quality
evidence has been lacking.
This study utilised data collected for the Canadian
Neonatal Network (CNN) and the Canadian
Neonatal Follow-Up Network (CNFUN) over a 21
month period and found 27 babies born 3 dioptres, >1
dioptre progression per year) aged under 18 years
to receive atropine 0.5% drops and followed them
for 12 months. The mean age was 10.3 years (range
2.7-16.8 years), the mean baseline myopia -6.6
dioptres and 70% were European, 8% African with
the remainder Asian. Only 60 (78%) adhered to the
treatment for the whole 12 months.
The 12 month results showed the mean myopic
progression had decreased from 1 dioptre per
year pre-treatment, to 0.1 dioptre per year during
treatment. Of note over 70% reported photophobia
and 37% experienced reading problems.
Comment: Although the description of the
authors’ in treating a predominantly non-Asian
population with atropine drops to prevent myopic
progression is appreciated, unfortunately this
study began enrollment just before the ATOM2
study was published, and thus a higher 0.5% dose
was used with inherent side-effect limitations. It
is also unfortunate axial length progression before
and during treatment was not assessed, as this
underpins the supposed mechanism of action of
atropine in myopia. Another limitation is the lack
of a control group, especially when the authors
state that the ‘treatment effect’ was greatest in
teenage subjects – as of course older teens will have
a slower rate of axial elongation anyway. However,
there is now evidence to support the use of atropine
to prevent myopic progression in a non-Asian
population, and we can look forward to further
studies investigating the currently favoured 0.01%
dose to compare to the ATOM2 study results.
ABOUT THE AUTHOR
* Dr Logan Mitchell is a
consultant ophthalmologist
specialising in strabismus,
cornea/external eye disease
and general ophthalmology
at Dunedin Hospital and
Marinoto Clinic, Dunedin. He
is also clinical senior lecturer
at the University of Otago
Dunedin School of Medicine.
July 2016
NEW ZEALAND OPTICS
13

SPECIAL FEATURE: O SHOW 2016
More than a show!
ODMA and the O-Show are more than just
shows, stressed Finola Carey, executive
director of ODMA. They are owned and
operated by the main industry players and all
profits are returned to the industry in the form of
scholarships and other supporting initiatives. This
includes grants and programmes to support new
optical dispensers and people wishing to open
their own practices, says Carey. “[For example] we
invested $100,000 in the clinic at the university
of New South Wales to give it a proper retail
outlet and we provide trained optical dispensing
mentors at the University.”
Facing significant competition for the first time
with the launch of Silmo Sydney—the newest
event from the owners of the famed Silmo Paris
optical fair, which will be held for the first time,
just four months prior to ODMA at the same
venue in Sydney—Carey was keen to remind the
industry what sets the ODMA and O-Show’s apart
and to explain that the O-Show was not some
knee-jerk reaction to the increased competition.
Plans for a more relaxed, boutique event in
Melbourne have been milling around since about
1996, she says, though it took another decade to
put plans together and yet another before ODMA
thought the time was right to launch it. “Industry
was saying to us that people are so tied up with
CPD that they need an event where they can just
come and look at product. CPD is working! This
is an opportunity to shop and have fun and learn
on the floor, but in an informal environment that
doesn’t feel like they are working.”
Given the tight timeframe and the new style of
the O-Show, Carey says the industry was realistic
in its expectations so was delighted to attract
34 exhibitors—significantly more than the 20
they initially thought they’d get. “We were really
stoked. We’ve had amazing support from all
the equipment companies, from the Melbourne
companies and members of ODMA. They have
been fantastic.”
Carey also praised ODMA’s new exhibition
organisers the IEC Group who turned the show
around in the tight timeframe and who replaced
Expertise Events, ODMA’s former exhibition
company, now organisers of Silmo Sydney.
ODMA chair Robert Sparkes says he spoke to
a number of exhibitors and overall everyone
appeared delighted with the inaugural O-Show.
“ODMA has been responding to the needs of
independent optics for over 50 years and will
continue to do so. The O-Show was a perfect
example of how we answer those demands. It has
been a great success and a good launching platform
for ODMA ‘17. And I would think that we will look
forward to rolling out the O-Show in the future in
other locations other than Melbourne.” ▀
A busy OptiMed stand
Essilor’s Brad White with Alex Tak and the Nautilus VR device
Facts, figures
and ODMA 2017
Owned and run by the Australian Optical
Distributors and Manufacturers
Association (ODMA), the O-Show was
conceived as a “pop-up, boutique event” to fill
the space between the large, biennial ODMA
trade fair.
It was put together in just a few months, after
being launched on 8 March so it didn’t impact
on the Southern Regional Congress’ (SRC’s)
annual conference. Despite this, the show still
attracted more than 800 pre-registrations and
more than 700 industry visitors over the two
days. Most were from the home state, Victoria
(76.4%) followed by New South Wales (11.2%),
and there were more than 40 from New
Zealand (0.6%).
The show was held from 21-22 May in the
fairy-light bedecked Shed 14 on the Central
Pier in Melbourne’s docklands. It attracted 34
exhibitors, including most of the big equipment
companies and several frames designers and
distributors.
A highlight was the cocktail party on the
Saturday night, complete with waiters, canapés
and a swing band, which allowed attendees
and exhibitors to relax and chat, and provided
the perfect opportunity for the organisers to
announce the dates for next year’s main ODMA
event. This will be held at the newly built
International Convention Centre in Sydney’s
Darling Harbour from 7 to 9 July, 2017.
Where the first day of the O-Show event
attracted far more people than expected, given
it was a Saturday afternoon and many were
expected to still be working, the Sunday started
off well and then petered out quickly, raising the
question from some exhibitors about whether
Sunday should have been a half day instead of a
full day. Despite this, the overwhelming feedback
from the majority of exhibitors was that it was
a fun and relaxed event, which offered some
real opportunities to do business and build
relationships with customers. ▀
Robert Sparkes, OptiMed CEO and ODMA chair
NZ Optics’ Lesley Springall gets into the Mersey Beat with Optique Line
CliC’s Helen Najar and B+D’s Candelaria Pourtale
O-Show providing some boutique charm
O-Show: small but
perfectly formed
BY LESLEY SPRINGALL
There weren’t the crowds, but there was
atmosphere, a camaraderie of spirit, lots
of tips on how to improve your business’
bottom line and people genuinely looking to learn
about and buy new equipment and frames. In a
few words, the inaugural O-Show in Melbourne
was small but perfectly formed.
Unlike other shows, the inaugural O-Show
was one of the first shows to actually give
attendees time to learn about and compare new
technologies, says exhibitor Ryan Heggie, Device
Technologies’ product manager.
“What has been great about the O-Show is
that we have continuous engagement with the
delegates and that benefits both the delegates
and the exhibitors. Educational content is very
important at other conferences, but when the
lectures are on we find we get a 20-minute block
when the delegates come out for morning tea and
we’re all run ragged on the booth, then the bell
goes and it’s straight back into the lecture hall.
“Here, we have a fun, vibrant atmosphere and
no time restrictions on how long people can spend
looking at equipment and talking to us, so they can
thoroughly explore the technology and compare
equipment and costs with other exhibitors.”
The boutique feeling of the show was also
a drawcard to new practice owners, which is
particularly great for exhibitors, added Hoya’s
national customer services manager Sara Leonard.
Fellow exhibitor, Medmont’s Jason Anderson,
agreed the relaxed atmosphere was a key selling
point of the new show. “I hope it continues,
whether it stays here or moves around state-bystate,
I think it’s got a future in the industry.”
Here’s a snapshot of what was attracting the
most interest on stands from some of the O-Show’s
more New Zealand-centric exhibitors:
Clic and B+D
New at the show and new for Australasia was the
new Danish B+D (pronounced B plus D) unisex,
ready reader ranges: attractive, fashionable,
strong and colourful reading glasses, that come in
a variety of styles including folding, full rim and
rimless, polarised and mirrored. The new ranges
14 NEW ZEALAND OPTICS July 2016

were featured on the CliC Eyewear stand as it will be
distributed by CliC in Australia and New Zealand.
They are designed to give optometrists the
opportunity to tackle the ready reader market head
on with a full range, quality product, says CliC’s
Helen Najar. “This is the second day of our launch…
and the range has been very well received so far. It’s
attracted a lot of attention.
“What appeals most to me about it, is it’s a high
quality, over-the-counter, readymade reader which
is what I do, and there’s a big demand for this in the
optical market.”
CliC are magnetic connection eyewear that hang
around your neck. They were designed (as the story
goes on CliC’s website) by Ron Lando of California
for NASA for astronauts requiring glasses that were
‘anti-gravity’ so they wouldn’t float off the face in
space. Nearly 15 years on, the product has reached
worldwide success in the domestic eyewear market;
is distributed in more than 27 countries and is CE
certified.
Najar says she hopes to be showing the new CliC
range and the beautiful, brand new B+D ranges to
independent optometry practices in New Zealand
later this year.
Essilor
Essilor’s new Eyezen lens was attracting plenty
of questions on the Essilor stand. The lens was
developed specifically to protect against increasing
screen use and won a gold award at Silmo Paris last
year. But it wasn’t the main drawcard on the stand.
That honour fell to Essilor’s new 3D virtual reality
headset, Nautilus, which has been designed to
allow consumers to see what a difference certain
lenses, such as progressive lenses, and lens
coatings can make. According to the company, the
simulation works via a smartphone app that is
placed in the virtual reality headset and controlled
by a tablet. It gives the wearer an interactive 360°
experience of different options selected by their
eye care professional from lens design, coatings
such as polarised or photochromic, to the effects
of dust and fog.
The Nautilus was introduced at Silmo in Paris
last year. Since then more than 5,000 units have
been sold to practices in Europe, but it’s only
recently released for sale in Australasia, says
Essilor account manager Brad White. “We’ve
found that the average selling price of a pair of
glasses increases because of the experience the
customer has.”
Tomato Glasses and Catimini
Another first at the O-Show was the brand new,
trendy children’s range of glasses from popular
French kids’ fashion label Catimini. The new,
brightly coloured, strong, often-accessorised
range—the girls’ glasses have beautiful little
detachable features such as feathers and beads
on them is being distributed by Tomato Glasses’
husband and wife distributor team, behavioural COVERAGE
optometrist Nicky Kiparissis Single: and Andrew up to 17mm Markakis. diameter
Stitched: up to 22mm diameter
“The Catimini range is fun and fashionable and
I love it because it’s small,” says Kiparissis. FIELD “We’re OF VIEW
getting huge interest here. Adults Single: are H22mm disappointed x V17mm
they can’t get it in their sizes.” Stitched: H22mm x V22mm
Catimini complements MEASUREMENT Tomato Glasses because POINTS
it offers a wider fashion range for parents and kids 32,400
who are looking for that, she says, whereas Tomato
ANALYZED POINTS
glasses are particularly popular for young children, 1,000,000+
especially those who are Down syndrome or who
do a lot of sports, SHIPPING as they are DIMENSIONS/WEIGHT
comfortable, fully
Head: 14” x 14” x 12”
adjustable for different face shapes (both the nose
(36cm x 36cm x 30cm)
pads and arms can be altered easily by the 15lb. parent), (6.8kg)
flexible and come in a range of colours.
Manipulator: 14” x 13.5” x 7.5”
(36cm x 34cm x 19 cm)
12lb. (5.44kg)
Chinrest: 21” x 10.5” x 3”
(53cm x 27cm x 8cm)
5lb. (2.26kg)
Base: 20” x 14” x 3”
(51cm x 36cm x 8cm)
7lb. (3.2kg)
FOOTPRINT
Width: 9.5” x 13.5” x 6”
(24cm x 34cm x 15cm)
varied width from patient to doctor
Depth: 17” (43cm)
Height: 19”-21” (48cm - 53cm)
[with head fully lowered and fully raised]
WEIGHT
Est. 11lb. (5kg) (head only)
POWER REQUIREMENTS
5V DC 3A
SUPPLIED PC
HP Envy 15” i7
8GB RAM
Tomato Glasses’ Andrew Markakis and Nicky Kiparissis introducing
Catimini
OptiMed
Attracting particular attention on OptiMed’s stand
was the Eidon confocal scanner, which received
FDA clearance in December 2014. According to the
manufacturing company, the Eidon is the first true
colour confocal scanner, providing unsurpassed
image quality, 60° field in a single exposure, 110-
120° field in auto wide field mode and 150° field
in manual mode, as well as a live, confocal view of
the retina, opening new opportunities in retinal
diagnostics.
OptiMed CEO Robert Sparkes says there’s been
a big push in the market for widefield imaging for
independents, resulting in the interest in the Eidon
at the show.
Also attracting attention was Optopol’s new SOCT
Copernicus REVO, a fully automatic, feature-packed,
easy-to-use, market-entry level OCT, says Sparkes,
which will also offer OCT biometry later in the year.
Optique Line
Popular Australasian frames company Optique
Line was attracting a lot of attention at the show
for its new Mersey Beat Eyewear range, plus the
opportunity to don a pair of beautiful 1960s English
music revolution-inspired acetate frames, a not-soflattering
black or white wig, and rock it out with
the on-stand drum kit or guitar (see Optique Line’s
Facebook page for the results).
Launching officially on 1 July, the beautiful Mersey
Beat Eyewear range includes 22 models, all paying
homage to the retro stylings of the early 1960’s
but with a contemporary twist. The UK-inspired
collection is described as “personality plus, designed
for the fashion forward and the young at heart,
available in a variety of materials including multilayered
acetates and carbon fibre, and featuring
edgy colour combinations.”
It’s the finish of it, the quality of it, that’s attracting
attention, says Optique Line founder John Nicola.
“It’s also at a great price point for retailers, so the
interest has really been phenomenal.”
CLC
sMap3D SPECS + FEATURES
Corneal Lens Corporation was at the O-Show to
launch the sMap 3D Precision Surface mapping
system and fluorescence-based structured light
topographer HIGHLIGHTS to the Australian market and remind
the New • Fluorescence Zealand market based this structured “revolution” light in scleral
lens fitting topographer was now with available. more than 22mm range
and 360
Like other exhibitors o scleral coverage
NZ Optics spoke to, the
• Under the eyelid scleral measurements
opportunity to actually be able to spend some time
• Over 1 million measurement points with
with people a 10 micron at the show precision to demonstrate how the
equipment • Integrated works software and is different, for fitting at and a pace that
is comfortable customizing for the Europa practitioner, Scleral lenses has been with a direct real
benefit, ordering says CLC’s capabilities Graeme Curtis.
“Here • Unbeatable it’s all about Price quality time with the
practitioner. They are interested in technology
and FEATURED they need time MAPS to decide which technology
• Sagittal Elevation
they are going to go with and because ours is very
• Texture-mapped image elevation
specialised
• Lens
it’s
Elevation
attracting a lot of interest.”
Curtis • Mean has also curvature been collecting feedback on the
• Simulated fluorescein pattern
• Corneal and Scleral Elevation (Best-fit
sphere)
• Polar display
• Full 3D display
TOOLS
• Principle toricity display at varying diameters
• Distance measurement
• Mean sagittal height at varying diameters
• Lens and sagittal height cross-section display
• Customizable Data tips
• Customizable color scales
• Brightness and contrast adjustments
• Customizable for multiple users
• Online storage
CONTACT LENS FITTING
• Scleral Lenses
- Normal Corneas
- Irregular Corneas
• Customized Soft Lenses
• Customized Back Surfaces
HVID/VVID MEASUREMENT
CLC’s Graeme Curtis discusses the benefits of the sMap 3D
Zeiss’ Kim Nguyen and Renato Antolovich
new sMap 3D since the CCLS conference in March
to feed back to the American manufacturers to
ensure it meets the needs of the New Zealand and
the Australian markets. He says these additions
and alterations will be available in a few months.
“For those specialist practices, this is certainly the
machine to beat.”
Jono Hennessy
One of the most colourful and permanently busy
stands at the O-Show was Jono Hennessy’s. The
Australian eyewear designer Jono Hennessy-Sceats
said the O-Show was great because it’s so personal.
“It’s a family industry,” added Louise Sceats,
managing director of Jono Hennessy.
The stand clearly demonstrated what was hot
on the frame scene at the moment. “It’s all about
colour and pattern. Colour for women and men too…
harking back to the ‘80s where you could really show
your personality through your glasses. Blue is still
huge,” says Louise Sceats.
Jono Hennessy sells all over the world (in New
Zealand via Phoenix Eyewear) and produces only
limited editions of each of its frames. Of particularly
interest was Jono Hennessy’s Liberty of London’s
fabric range and its Carter Bond range, one of the
first in the world to produce wood-finish acetate
frames using natural looking materials.
Device Technologies taking a little more time to explain new
technologies
Jono Hennessy’s Louise and Jono Sceats
Device
Technologies
On Device
Technologies’
stand OCT was
the big drawcard
as it’s now so
affordable and easy
to use, says Ryan
Heggie, Device
Technologies’
product manager.
“OCT has come
such a long way in
Optique Line launched its Mersey
Beat Eyewear range at the O-Show
the last five years. It’s evolved to the point where
it’s a really quick and easy process to perform a
comprehensive retinal screening for all patients, not
just a select few.”
Device Technologies’ Topcon OCT range is
particularly popular because they are so easy to use,
he says, allowing front of house staff to take the
scan, leaving the optometrist more time to do the
analysis, diagnosis and evaluation of the results.
Another drawcard for Device Technologies’ was its
TearScience LipiView and LipiFlow technology for
the diagnosis and treatment of evaporative dry eye.
According to the product information, the
CONTINUED ON P16
A Revolution in Scleral Lens Fitting
www.corneal-lens.co.nz
Visionary Optics is the exclusive US Distributor of the sMap3D.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a licensed practitioner.
www.corneal-lens.co.nz
+64 (0)3 366 6247 | 2 Ballarat Way Wigram 8042 Christchurch New Zealand
July 2016
NEW ZEALAND OPTICS
15

SPECIAL FEATURE: O SHOW 2016
Hoya’s Sara Leonard and the Vision Simulator
CONTINUED FROM P15
The Clarity 20/20 team Robert Cormack, David Cormack, John
Whelan, Paul Hillier and chairman Geoffrey Cottrell
Artemiss’ Jaimee Kearns
system moves dry eye treatment from the
pharmacy to the clinical practice. The LipiView
ocular surface interferometer enables the clinician
to define, measure and track lipid deficient
evaporative dry eye, while the LipiFlow reactivates
the eye’s lipid secreting glands to reduce or
eliminate dry eye symptoms.
Zeiss
Demonstrations of Zeiss AngioPlex, the company’s
latest offering in the increasingly popular field of
OCT angiography, was proving popular on the Zeiss
stand.
“It’s about being able to demonstrate
the capabilities of the technology because
optometrists haven’t really had access to this in
the past,” says Zeiss clinical support specialist
Kim Nguyen, adding that the speed and ease of
use was particularly appealing to the market,
especially as more optometrists are taking over
more of the management role for glaucoma
patients.
Hoya
Hoya’s new light reactive lens Sensity was one
of the main points of conversation on the Hoya
stand. Sensity is the company’s latest innovation
in photochromatic technology to provide
comfortable vision and consistent performance in
all light conditions and weather circumstances.
But the real drawcard, which took the company
a little by surprise, admits Sara Leonard, Hoya’s
national customer services manager, was Hoya’s
new virtual reality Vision Simulator system. “It’s
in a beta stage of development at the moment,
but it’s a great dispensing tool that simulates the
multifocal experience for patients.”
The simulator offers patients the opportunity to
“see before they buy” to examine the differences
between different types of lenses and even
coatings. It should be launched late this year or
early next year.
Designs for Vision
The interest in dry eye and the increasing amount
of equipment coming on the market to diagnose,
map and treat dry eye was also evident on Designs
for Vision (DFV) stand, with the company’s Oculus
Keratograph 5 attracting a great deal of interest.
The Oculus combines corneal topography with dry
eye analysis, including tear film break-up time and
meniscus height, the quality of the lipid layer and
Meibomian gland dysfunction.
Tamara Smart, DFV’s sales and marketing
specialist, says it’s one of the only instruments on
the market that’s easy to use, looks at all aspects
of dry eye and allows state-of-the-art corneal
topography at an affordable price.
The O-Show also marked DFV’s launch of Finnish
company Icare’s ic100 non-contact tonometer,
which requires no drops, air or
calibration or specialist skills to
use. “It is so quick and easy, very
accurate and so popular. It’s the gold
standard,” says Smart.
Clarity 2020
Still relatively new to the Australian
market, Kiwi company Clarity
2020 was at the O-Show to launch
itself into the Victorian market
by explaining how its spectacles’
cover for practices “acts like glue
to stick patients to your practice,”
providing a customer-service add on
that can provide that vital element
of difference independent practices
require.
It encourages people to return to the
practice should they break their glasses
and gives them a certain amount of
confidence to invest more in the glasses
they want, rather than just settle for
those they think they can afford, says director
Robert Cormack.
Heidelberg Engineering
On the Heidelberg Engineering stand interest was
focused on the company’s Spectralis platform,
which provides multiple models at various price
points. “The whole package has been designed to be
upgradeable through life, so eye care professionals
can start with what they need and add the different
functions as they grow and change,” says regional
sales manager Adam Hamilton.
The workhorse model in the family is the
Spectralis OCT, which according to the product
information is an economical, easy-to-use
version with one-touch pre-set scan patterns and
AutoRescan. Additional models build upon this
base platform allowing clinicians to add widefield
imaging and angiography.*
Medmont
On the Medmont stand, the centre of attention
was the newly released Medmont Studio 6.1
with its new tear film analysis package for the
company’s Medmot E300 Corneal Topographer.
“It’s the only non-invasive way of mapping the tear
film,” says business development manager Jason
Anderson. “It’s an added benefit, especially for
those interested in speciality contact lens fitting…
as there’s not really much else on the market for
analysing the tear film.”
Further developments are expected to be
announced early next year, says Anderson adding it
was a still a little early to say more.*
*Heidelberg Engineering and Medmont products
are distributed by the Ophthalmic Instrument
Company (OIC) in New Zealand ▀
Designs for Vision’s Tamara Smart shows off the new ic100
Heidelberg Engineering’s Adam Hamilton
Business snapshot a hit
Though
there were
deliberately
no CPD-earning
lectures at the
O-Show, there was
still quite a bit
of interest from
delegates in the
exhibitor product
demonstrations and
Business Snapshot
seminars held on an
open stage in the
centre of the show.
Keynote speakers
Mark Davis, Robert
Springer and Paul
Hillier presented on
a number of business
marketing-related topics.
• Mark Davis, from the Melbourne Education
& Training Centre, regaled the audience with
colourful accounts of his own experience of poor
customer service, explaining how this can mean
the difference between retaining a customer for
life and seeing them walk promptly out the door,
never to return. “It’s about being able to offer a
level of customer service that means they don’t
want to go anywhere else.”
Every industry faces change and even revolution
from time to time, but employing the
fundamentals of good customer service, nailing
that first impression and ensuring everyone in
your business understands how important that
is, and how to talk and engage customers from
thereon in, will ensure your business not only
survives, but thrives, he said.
• Paul Hillier, director of Clarity 2020, continued
the theme of good customer service, explaining
how important it is for optometrists to retain
patients in this increasingly competitive world.
“It’s much easier to retain existing patients as
opposed to go off and search for new ones.” But
it is difficult to build relationships with people
when you’re only seeing them once every 12 to 24
months, so you need reasons to engage with them,
he said.
• This was also the theme for the third keynote
speaker, Robert Springer, who after working for a
number of years for Zeiss and Essilor has now set
up his own company OptomEDGE to help practices
engage better with patients using the plethora of
free online tools available. All communication with
patients must be seen as personal, with content
tailored to their needs or they are just not going to
remain engaged, he said.
Another key, standing-room-only, attraction was
the 15-minute window dressing presentations
Distributed in Australia & New Zealand by:
Andrew Markakis
14 Parker St, WILLIAMSTOWN 3016
Phone: +61 3 8430 0441 Mobile: +61 426427277
Mark Davis tackles the importance of
good customer service
Kerry Van Beuge enthralled audiences with some quick, clever and
eye-catching window dressing ideas
by Kerry Van Beuge from Through the Looking
Glass, with each demonstrating just how easy
and effective it was to make an attractive window
display by focusing on a particular theme. ▀
ODMA
Award
New Zealand-born fashion bloggerturned
Australian-based dispensing
optician (and new columnist for NZ
Optics, see p19) Jo Eaton (left) was awarded the
ODMA 2016 Dispensing Award grant of $2,000
by ODMA executive director Finola Carey (right)
to help her complete her studies. ▀
16 NEW ZEALAND OPTICS July 2016

with
Prof Charles McGhee
& A/Prof Dipika Patel
Series Editors
Intraocular foreign bodies.
What to do?
Fig 1. This patient developed endophthalmitis from an intraocular body that penetrated the
cornea, see sutured entry site. The IOFB in the photograph is secured in foreign body forceps
and about to be removed from the eye.
Fig 2. An IOFB lodged in the ciliary body has been detached from the surrounding tissue and is
about to be explanted from the eye.
BY ASSOCIATE PROFESSOR PHILIP POLKINGHORNE*
A
lot of the discourse on intraocular foreign bodies (IOFBs)
is concentrated on the morbidity associated with their
presence, timing of surgery and risk of endophthalmitis. All
important issues, but often neglected is the management of the
most common IOFB, the intraocular lens and or medical devices
that have become displaced and or adversely impacting on adjacent
structures. Such iatrogenic IOFBs by definition are much more
frequently encountered than those IOFBs from penetrating trauma.
In New Zealand we have relatively good statistics on ocular
trauma, because of ACC. On their website for the financial year
ending 2015, 30,000 ocular injuries were recorded. The website
does differentiate between types of injury, including foreign body
injuries (n=13,714) but the absolute numbers of intraocular foreign
bodies are not recorded. That data however can be extrapolated
from a recent survey performed in Waikato suggesting about 16
traumatic intraocular foreign bodies would be expected per year in
New Zealand. The authors of this paper also provide useful data on
the risks of infection associated with traumatic IOFBs (about 15%)
and the risk of evisceration (about 5%). 1
Overseas experience suggests infection is linked with delay in
presentation and when the foreign body is organic, particularly
when the object is wood and or contaminated with soil. Many
practitioners would advocate the prophylactic use of antibiotics and
tetanus toxoid in this scenario. In my own practice I tend not to use
prophylactic antibiotics for high velocity, metallic foreign bodies but
have a low threshold for organic IOFBs especially if a gas bubble is
seen in the eye.
The history is certainly important, not only to consider the
presence of an IOFB in an eye that has been traumatised, but to
provide an indication as to the type of foreign body. The ocular
examination may be difficult, especially in the presence of globe
rupture but in a closed globe setting a small corneal laceration, iris
defect and or sectorial lens opacity should suggest the presence of
an IOFB.
In figure 1 you can see that expert ultrasonography obviates the
need for other types of imaging, but most patients are aggrieved
if an IOFB is missed following trauma. Where there is doubt, a
plain X-ray will exclude larger metallic foreign bodies, but for
other IOFBs there is a risk of a false negative result. Many overseas
centres use CT scanning with 3 mm cuts to lessen this risk. MRI is
contra-indicated in the presence of metallic foreign bodies since the
electro-magnetic field can displace the IOFB, potentially damaging
adjacent intraocular structures but is useful in some instances of
non-metallic foreign bodies.
Of course not all IOFBs need to be removed and inert substances
such as plastics and glass fragments can be often left safely in the
eye. Many patients require reassurance if that advice is given. I find
a second opinion from another colleague is useful in that scenario.
If removal of the IOFB is indicated, I prefer, as a rule to defer
surgery for a week or two, to enable a posterior vitreous separation
to occur. Nearly all patients share the demographic of being male
and aged under 30 years, so if the foreign body is small and the
wound self-sealing I think it is better to wait for the vitreous
separation. The exception to this policy is where there is a suspicion
of contamination. Prompt vitrectomy and intra-vitreal antibiotics
is mandatory in that circumstance. The presence of an IOFB in an
eye with an open globe injury is an absolute indication for acute,
primary closure but again I would tend to defer removal of the
foreign body for a week or so.
I don’t think the location influences the timing of the surgery.
In my hands IOFBs in the ciliary body or ora are more difficult to
remove than those behind the equator. Sometimes the lens may
have to be sacrificed in anteriorly located IOFBs. One recent case
required three surgeries to locate the IOFB within the ciliary body.
(See figure 2). Persistence was required in that case because of the
risk of siderosis.
All posterior segment IOFBs require a vitrectomy. If there are
media opacities such as cornea scars and/or cataract, combined
surgery may be needed. I find it very helpful to engage an anterior
segment specialist if a temporary kerato-prosthesis is likely to be
needed during the proposed surgery. Their skill in facilitating a
closed environment is vastly superior to any open-sky technique
of old. Conversely, combining cataract vitrectomy surgery usually
requires only one operator.
IOFBs embedded in the retina or choroid requires careful
dissection, good haemostasis and tamponade with gas or oil
is often essential. (See figure 3). Of course not all IOFBs need
to be removed and inert substances such as plastics and glass
fragments can be often left safely in the eye. Many patients require
reassurance if that advice is given. I find a second opinion from a
colleague is useful in that scenario.
As a rule, stable intraocular lenses are not normally a hindrance
to removing an IOFB and similarly a clear crystalline lens can be
left in situ. I place more importance on removing as much vitreous
as possible to safely remove the IOFB but try not to overstep the
mark with a zealous approach to the vitreous. Many IOFBs are
encapsulated at the time of surgery and some dissection is usually
required. This can be achieved with a MVR blade or 25-gauge needle
on a 1 or 3 ml syringe. The capsule is dissected sufficient to free
the IOFB, or at least mobilise. As for the forceps I use the smallest
that will safely lift the foreign body and guide it through the
sclerotomy. The later generally needs to be enlarged, as a rule twice
the size you initially calculate. I generally find magnetic probes (rare
earth magnets) are not sufficient to retain contact through the
sclerotomy.
Very large IOFBs, (greater than 10 mm), may have to be removed
through the anterior segment, although this depends on the width
of the foreign body.
Dislocated intraocular lenses, and other therapeutic devices such
as capsular tension rings should be removed when dislocated, but
optical considerations outweigh any perceived risk to the retina.
The intraocular lens may be able to be correctly relocated into the
pupillary aperture and stabilised, usually by means of a prolene
suture but this does require a haptic profile that lends to that
approach. There is a wide range of capsular tension rings that have
been inserted in the last decade; some eyes have more than one
device. Removal requires a dialing action not only to free from an
intraocular attachment in or about the pupillary plane but also
from the anterior segment. That approach will limit the size of the
ab externo incision.
The upsurge in the use of selective corneal tissue, particularly
endothelial grafting has created a new, albeit very rare complication
where the tissue can become dislodged and settle on another
intraocular structure. If this tissue enters the posterior segment
then removal and relocation should be performed as soon as
possible, before the cornea becomes oedematous and the view
difficult. (See figure 4). Furthermore if the tissue is rapidly relocated
then it should continue to act as originally intended.
In summary iatrogenic IOFBs are more numerous than those
resulting from traumatic causes but the later have the propensity to
cause more medico-legal problems. ▀
References
1. Pandita A, Merriman M. Ocular Trauma Epidemiology: 10-year retrospective
study. NZ Med J. 2012: 125;61-69.
About the author
* Philip Polkinghorne is a vitreo-retinal surgeon in
Auckland, expert diver and fisherman.
Fig 3. Fundal photograph demonstrating an IOFB penetrating the retina near the macula.
Fig 4. Corneal Donor Tissue (comprising of a thin layer of corneal stroma, Descemets
membrane and corneal endothelium) on surface of the retina. This was subsequently
elevated and re-attached to the cornea.
July 2016
NEW ZEALAND OPTICS
17

Inaugural Glaucoma New Zealand
symposium announced
Problem Solving
We often see new patients on
referral from optometric or
ophthalmological colleagues,
and quite often too from family
members, friends or work colleagues
of the patient. They’re often told “Go
see Alan; he’ll sort out your problems!”
Such referrals, although flattering, can
be quite daunting and it certainly is a
challenge to deliver what people seek
and to meet or exceed expectations.
More often than not we do solve the
problems, often with excellent results.
There’s a process one needs to follow
and work through. The first thing I like
to have at my disposal, on first contact
with the patient, is their previous ocular
history. What’s been tried in the past?
If the previous practitioner has tried
contact lens A, B, C & D then I will avoid
repeating those. With a detailed review
of the data from my measurements –
comparing topography and manifest Rx,
corneal curvature - and refractive versus
corneal astigmatism - immediately
tells me what lenses would be ideal.
For example if we have no corneal
astigmatism but manifest spectacle
astigmatism then a soft-toric or
spectacles are indicated. An RGP would
not be, unless you’re an extremist who
thinks that front toric prism ballast
lenses are cool. There are of course many
other scenarios that I’ve covered in
previous columns over the decades and
thus will not repeat here.
These days too many practitioners
seem to ignore K readings and things
like HVID and pupil diameter and just go
for the generic 8.6/14.2 soft lens or their
‘preferred’ multifocal soft lens.
In a patient with very small pupils
a centre near multifocal may provide
decent near vision but there’s no way it
will provide adequate or safe distance
vision. Such patients are much more
likely to succeed with the judicious
choice of something like Biofinity D&N
MF lenses, appropriately fitted to the
dominant and non-dominant eyes.
All too often I see a patient with an
8.40mm corneal curvature who has
been fitted with an 8.4BC soft lens, that
is way too tight, too steep and exhibits
variable vision or is difficult to remove.
At the other end of the spectrum some
optometrists ‘prefer’ flat base curves but
a 9.0BC 1 Day lens is not going to work
too well on a steeper eye like a 7.2mm
corneal curvature. We also have to
consider eccentricity; a very flat eye with
low eccentricity (as flat corneas tend
to be) may not require the ‘standard’
flattening factor of say going 0.8 flatter
than K. Thus an 8.7mm radius cornea
may do well with a 9.0BC fitted only 0.3
flatter than K.
Similarly a steep cornea with high
eccentricity (as they tend to be) may do
well with a lens that is say 1.2mm flatter
than flattest K e.g. a 7.4mm steep cornea
may do well with an 8.6BC soft lens.
Nek Level
These are the things one learns by
experience and applying logic and first
principles but if you don’t measure
things or use the measurements you
have, then you will never work out
these relationships and just keep blindly
fitting your favourite generic 8.6/14.2 or
the lens your practice gets on the best
preferred-provider deal.
By applying some of the
aforementioned principles, I more often
than not put my first lens on the eye of
these frustrated patients — who have
had multiple practitioners apply multiple
lenses without success – and hey presto
we get a great result. Avoiding the
previous practitioners’ trials and errors,
makes us look good.
It also helps to use the latest
generation lenses that have the ultimate
performance, comfort and visual quality
and this further boosts your likelihood of
success: As opposed to using some longin-the-tooth
generic 55% water, 8.6/14.2
monthly disposable.
While doing some recent trials with
the latest Acuvue Oasys One Day lens I
had many such scenarios in patients who
were unhappy with numerous lenses,
over some months or years. We had
many ‘wow’ responses with better vision,
comfort and immediate orders of a bulk
supply of lenses. I so love it when a plan
comes together. So do my patients. Such
results beget even more referrals from
happy, enthusiastic patients.
Like I’ve always said it’s far better to
have enthusiastic referrers, which cost
you nothing, compared to expensive
marketing and advertising campaigns
that may deliver very few bums on seats.
That’s not to say one shouldn’t do
marketing and advertising or send out
newsletters or harness social media: Of
course one must as keeping your name
out there, in multiple media, will keep
reminding current, former and future
patients. When they need you they are
more likely to recall your name and come
and see you.
Not all patients want a free, quickie eye
test at a convenient chain. Many patients
are prepared to pay for longer consult
times, thorough investigations and top
quality products. Professionals should
not be providing important professional
services for free. It devalues our skills and
professionalism. Would a free accountant
or lawyer deliver the same professional
quality and thoroughness that a QC or
senior partner would provide? Methinks
not.
Au Contraire
In my discussions, lectures and writing
I often cite complex cases. The reason
I do this is that there’s not much point
getting excited about the performance
of a given lens on a simple -2.00 myope
with bullet proof corneas and no worries.
Throwing the toughest cases at a given
new lens, that’s promoted as the best
thing since sliced bread, soon sorts the
wheat from the chaff.
From time to time people get the
impression that a given lens I’m
discussing is only good for problem
solving. Au contraire! If a lens works
fantastically on the toughest cases
imagine how well it will do in simple
cases.
By fitting all your new cases with the
best lens available – that’s providing
performance levels that outstrip
competitors by two, three or nine times
in patient ratings — then surely the
logical step is to use the lens? At maybe
only a premium of 10% to 15% on price
(which is less than the difference per
day between a McDonald’s coffee and
a high end Barista coffee) your patients
will soon find out what the difference
is should they go ‘downmarket’ and get
fitted by a competitor with a ‘lesser’ lens?
Some even self-prescribe the cheapest
daily they can find on the Internet.
If the cheaper lens provides poorer
visual quality, reduced comfort, excess
movement, dry eye symptoms and redder
eyes then your job is done. Nothing
convinces a patient more than their
own experience. Such experiences also
reinforce the fact that you’ve done the
best you can, in their best interest.
If there’s a mantra to go by — be the
best you can be - is one to aspire to. ▀
Editor’s note and disclosure: Alan Saks was engaged by JJVC to share his
experiences fitting Acuvue Oasys 1-Day at the recent ANZ product launches.
He is not paid by any manufacturer to review or promote their products in
his column, which remains independent.
BY HANNAH KERSTEN FOR GNZ
Professor Helen Danesh-Meyer, glaucoma specialist
and chairperson of GNZ
On 18 September this year,
Glaucoma New Zealand (GNZ)
will be holding its inaugural
Glaucoma Symposium at Alexandra
Park in Auckland. Professor Helen
Danesh-Meyer, glaucoma specialist and
chairperson of GNZ, will be overseeing
the symposium programme.
One of the key mandates of GNZ
is glaucoma education - the webbased
GNZ Professional Education
Programme has been hugely supported
by the optometry profession. This
symposium is an extension of GNZ’s
commitment to glaucoma education.
Professor Danesh-Meyer says, “GNZ
has been wanting to implement the
idea for a couple of years – it seems
particularly timely given the increased
opportunity for optometrists to be
involved in glaucoma management.
Optometrists have a pivotal role in
the diagnosis of glaucoma. However,
now with therapeutic optometry,
optometrists are increasingly involved
in the ongoing care of glaucoma
patients, and are independently
prescribing glaucoma medications. The
more ophthalmology and optometry
interact and communicate, the better
the outcomes for our patients.”
This symposium is the first full-day
optometry education event in New
Zealand focused solely on glaucoma.
The conference has the support of
glaucoma specialists and will include
speakers from both optometry and
ophthalmology, including Professors
Danesh-Meyer and Charles McGhee,
Associate Professors Jennifer Craig
and Gordon Sanderson, Drs Mark
Donaldson, Dr Sam Kain, Sonya
Bennett, Hussain Patel, Shenton Chew,
Jay Meyer, Alex Buller, Alan Simpson,
Jesse Gale, Dean Corbett and Graham
Reeves, and optometrists Grant
Watters and Hannah Kersten.
Professor Danesh-Meyer hopes
July is Glaucoma
Awareness Month
Glaucoma New Zealand (GNZ)
is set to hold its Annual
Awareness Appeal in July. It is a
call to action – with a focus on getting
people to have their eyes examined,
raising awareness of glaucoma, and
generating vital funds to enable GNZ
to continue its sight-saving work.
“Raising funds for GNZ to keep
saving what most people consider
their most precious sense, sight,
plays an important role in this year’s
campaign,” says GNZ executive
manager, Helen Mawn. “Since 2002,
GNZ has strived to make glaucoma a
highly visible disease.”
GNZ offers services to everyone
affected by and concerned with
glaucoma; advocating for regular
eye checks, educating the public
and health professionals, providing
support and information to those
with glaucoma and their families, as
well as contributing to research.
This year GNZ is teaming up with
Cecily – a popular cartoon character
created by Cantabrian Celia Allison.
All through July, for every order at
www.cecily.co.nz that uses the code
“Glaucoma NZ” – 50% of the sale
will be donated to GNZ. Just enter
“Glaucoma NZ” in the instruction
box when you see “Your Cart”. Cecily
humour can be found on quality
merchandise such as lens cleaning
cloths, cards, calendars, stationery,
prints, tea towels and much more.
Have a laugh, make a purchase, and
help Cecily help GNZ.
Also lending their loyal support are
the optometrists, ophthalmologists,
and pharmacists around the country
who have taken GNZ’s donation boxes.
“Many optometrists and
ophthalmologists are also donating
$2 from each eye examination
undertaken during July and we
are grateful for the donations that
we have received in lieu of taking
donation boxes,” says Mawn.
About 91,000 New Zealanders over
the age of 40 have glaucoma and
more than half don’t know they have
it. Worldwide 64 million people have
glaucoma and that’s expected to grow
to 111.8 million worldwide by 2040.
For more information visit
www.glaucoma.org.nz ▀
that the GNZ Glaucoma Symposium
“provides both depth and breadth in
glaucoma care.” The overall theme
of the Symposium is Glaucoma –
from Diagnosis to Management.
The day will be divided into four
main sessions: glaucoma diagnosis,
special issues in glaucoma, glaucoma
treatment and case presentations.
Presentations at the Symposium
will cover fundamentals such as
optic nerve interpretation and
gonioscopy, as well as some of the
challenging issues in glaucoma such
as the treatment of normal tension
glaucoma and secondary glaucomas.
There will also be a special session in
which challenging glaucoma cases are
presented. GNZ is looking to apply for
six clinical diagnostic CPD points for
this one-day event.
GNZ would like to make this a regular
event, and hope to have an annual
Glaucoma Symposium, with each
event building on the previous year.
Professor Danesh-Meyer and GNZ are
very excited about this initiative and
look forward to bringing together both
ophthalmologists and optometrists in
September. ▀
Glaucoma New Zealand Symposium 2016
- Registration now open -
The inaugural Glaucoma New Zealand Symposium will be held
in September 2016. This is a one day education event for optometrists
and other eye health professionals.
WHERE: Alexandra Park Function Centre, Greenlane West Road, Auckland
WHEN: Sunday 18 September 2016, 9.00 am - 5.00 pm
CONFERENCE PROGRAMME: It will be an exciting one day symposium with
rapid-fire presentations on a wide range of glaucoma topics, including Glaucoma
Diagnosis, Special Issues in Glaucoma, Glaucoma Treatment and Challenging
Cases. The scientific programme is being overseen by Professor Helen Danesh-
Meyer and presentations will be given by glaucoma specialist ophthalmologists
and optometrists.
COST: $120 per delegate for a full day of glaucoma education
PROFESSIONAL EDUCATION: Application for 6 clinical diagnostic points
REGISTRATION: For more information and to register for the Glaucoma New
Zealand Symposium, visit www.glaucoma.org.nz
Thank you to our Silver Sponsors
18 NEW ZEALAND OPTICS July 2016

J&J launch HydraLuxe
Johnson & Johnson Vision Care launched its
new contact lens, Acuvue Oasys 1-Day with
HydraLuxe technology at a series of events in
Australia and Auckland in May.
The Auckland event at the Tamaki Yacht Club
on 25 May was the last on the roadshow, which
featured three speakers: Dr Emma Gillies, J&J’s
professional affairs manager; keynote speaker Dr
Brian Pall, senior principal research optometrist
at J&J in Jacksonville, Florida; and our own Alan
Saks, NZ Optics columnist on all things CL and
optometrist with Mortimer Hirst in Auckland.
Canapes and drinks and a couple of CPD points
added to the warm and welcoming atmosphere
as the speakers addressed a group of about 45 eye
care professionals.
Sean McKiernan, J&J’s national key account
manager ANZ, kicked off proceedings mentioning
the problems the CL industry has faced over the last
decade and how J&J hopes its new HydraLuxe lens
will change all that. “We can’t change everything,
but what we can do is start the journey to try and
get you to fall in love with contact lenses again.”
McKiernan pointed out that increasing the love
affair with CLs for patients could dramatically
effect an optometrist’s bottomline. In the UK, on
average, contact lens revenue represents 25% of
an optometrist’s total optical sales, whereas in
Australia and New Zealand it’s only 5%. “So there’s
really an opportunity for all of us,” said McKiernan.
Key to building up this revenue is stopping people
exiting the category, he said. In 2015, 302,000 new
wearers entered the CL category in Australia and
New Zealand, but 229,000 dropped out. One way to
keep new wearers is new products, said McKiernan.
Dr Gillies started her talk stating that the new
HydraLuxe lens is not Oasys mass produced. She
continued the theme of dropout by quoting a UK
study showing the main cause of dropout for new
wearers was dry eyes and discomfort. To tackle this
J&J commissioned a quantitative study of soft CL
wearers to better understand the lens-wearing
experience throughout the day; research that
focused J&J on the tear film and thus helped them
develop the HydraLuxe technology, she said.
Before tackling the science behind the technology,
an obviously passionate Dr Pall said the most
important thing the audience could do is to try the
lens for themselves. The technology is so good it can
speak for itself, he said.
As for the science, Dr Pall explained how the new
lens is an innovative new daily disposable silicone
hydrogel that’s designed to work with the key
components of the natural tear film to lubricate and
Obituary: Denis Kennemore
BY JOHN BILLINGS
It is with great sadness that I report the passing
of a friend and well-known character in the New
Zealand optical industry; Denis Kennemore. He
passed away peacefully at home, aged 83 years,
early Monday morning on 30 May.
Denis was born 1933 in Sydney. In 1948 he began
his working career at North Shore Gas Company
as a sheet metal worker but he soon moved on to
become an optical mechanic starting a five-year
apprenticeship with AG Thomson and Sons.
Denis left soon after completing his apprenticeship
to join Geddes as an optical technician where his
skills at fitting glass rimless frames stood him in
good stead and he was there until 1956 (apart from
1948 to 1952 when he did his National Service in
the Navy).
1956 brought the Melbourne Olympics and
being an ardent sports fan he wanted to go, so
resigned from Geddes. To fund the visit he went to
Melbourne and got a job glazing sunglasses. After
the Olympics he drove back to Sydney looking for
work, but nobody wanted an optical technician, so
he took a job painting the bottom of boats.
His next move was to join OPSM where he worked
in the lab. Knowing they were looking for smart
people to train in optical dispensing and wanting to
get on, he wore a shirt and tie to work. Eventually
this paid off and they asked him to train as an
optical dispenser in a store in downtown Sydney.
Shortly afterwards he was transferred as assistant
manager to Tamworth, a move not entirely with
his agreement but that would have life changing
consequences as it was here that he met Enid, the
lady who would later become his wife, lifetime
friend and, towards the end of his life, his intimate
carer. Always the keen sportsman, Denis played
rugby league here for a year but gave it up as, in his
words, “the ground was too hard!!”
Dr Brian Pall, Aki Gokul, Dr Emma Gillies and Alan Saks
Jenny Ogier and Cliff Harrison
moisturise the lens and support the patient’s tear
film during lens wear, thus minimising friction from
blinking and dryness.
In an article written and circulated by Dr Gillies,
the technology is described as “an enhanced
moisture network with increased covalent bonding
designed to further reduce the adhesiveness of the
lens to better mimic the eye’s own mucins.”
As well as explaining the science Pall also
presented the clinical evidence showing that in a
J&J study, twice as many wearers preferred the new
HydraLuxe lens compared with another leading
daily lens. “We think it’s a game changer. We hope
you will continue to be as surprised as we are.”
Alan Saks took a more personal approach to the
new lens, sharing some particularly difficult CL
patient case studies and explaining what happened
when he decided to trial the new HydraLuxe lens on
them. All fell instantly in love with the new lenses,
he said, and most also experienced some degree of
improved vision. “It’s my first choice for new and
existing wearers,” he said simply.
“And you never get a second chance to make a
good first impression,” summarised Dr Gillies. ▀
After marrying at
Christmas in 1960,
Denis and Enid
moved to Wellington
for a three-year
stint. However, an
opportunity with Optical Prescription Spectacle
Makers NZ arose, and Denis purchased 51% of
the business. Denis and Enid were to stay in
New Zealand.
In July 1961 ADONZ was formed by eight
founding members, including Denis. A key
milestone was the success he achieved through
tough negotiations for the exclusive use of the
title “dispensing optician” by people registered
under the new opticians Act of 1977. Denis was
the first dispensing optician to be appointed by
the Board and the first registered DO in New
Zealand holding the registration number 61-
00001, a fact of which he was extremely proud.
In 1982 he owned a store in Capital on the Quay
where he showed forward thinking by being one
of the first practices to display frames rather than
having them in drawers. In 1988 Denis was elected
a Life Member of ADONZ. In 1990 Denis was the
first DO to employ an optometrist and in November
1990 opened another store in Porirua.
Unfortunately, in 1992 he began having health
problems and in 1993 underwent heart surgery,
which is where I came onto the scene. He brought
me out from the UK to work for him as a DO in
the Porirua store. Due to his ill health, he and Enid
decided to sell the business and in November 1994,
OPSM Australia purchased Optical Prescription
Spectacle Makers NZ.
On their retirement Denis and Enid established
the Kennemore Education Fund. This fund
was initially established to support struggling
Ahead of the game
Style-Eyes
It was 1995 when I got my first pair of
glasses and I don’t recall a single pair seeming
fashionable. ‘Geek chic’ was yet to become a
trend and bespectacled teenagers around the
country were all given the same nickname of
‘nerd’. The only recollection I have of anyone
wearing glasses as a fashion item was Lisa
Loeb’s tortoiseshell cat eye frames in her 1994
music video for ‘Stay’.
I chose my very first pair because they
seemed handsome and well-made. They
were light, round metal frames with subtle
engraving. In 2016, this exact style is finally in
fashion. Is this proof of the theory that fashion
is currently on a cycle of around twenty years?
Maybe I was just ahead of my time!
I never loved my first pair of glasses the way
I love the frames I have owned since. I finally
took inspiration from Lisa Loeb at the age of
18 in 1998 and got a pair of retro-inspired
tortoiseshell frames. Glasses became my
‘thing’.
After this, I made my way through several
rectangular pairs that were very popular in the
early 2000s. Forest green! Lilac! Wave patterns
on the temples! Apart from the colours, there
was nothing particularly interesting about
them. I was yet to discover the delightful
world of independent designers and deadstock
vintage frames!
My first foray into something slightly unusual
were some Modo frames. I loved the temple
position. They also had crystal temples with
embedded glitter! These frames could not be
worn to the pub, lest some clever intoxicated
person insist I was wearing my glasses upside
down and that they simply must try them on!
This was just the beginning. I was hooked.
Around the time I purchased the Modo frames,
I decided to consult the internet for eyewear
advice. It was 2008 and the independent
fashion blog craze was well underway. You
could find blogs about almost every fashion
item, except eyewear. I had been making
websites since I was a teenager in the late
‘90s so, of course, I started my own and
eyeheartglasses.com was born. I barely
knew anything, except that I loved the look
of eyewear and all of my friends and family
consulted me if they needed a shopping buddy
students in their education and Denis and Enid
have been generous in their contributions every
year since. In later years as the fund grew, it was
able to support every New Zealand student DO
with the purchase of their text books. While
Denis retired from optics, he still kept a keen
eye on what was happening, and after he lost
the ability to read after several strokes, would
get Enid to read him the NZ Optics magazine
news articles. He retained his non-practising
registration status right up until his death.
Denis was not only involved with the optical
industry, but he threw his heart and soul into
everything he had an interest in, be that bowls, golf,
horse racing or the local community. In 2014 Denis
and Enid were recognised by the Porirua Mayor,
being awarded a Mayoral Certificate of Recognition
for voluntary services to their community
Denis was a straight shooter, who told things as
they were and didn’t suffer fools. Sometimes this
came across as him being described by some as a
“grumpy bugger” but beneath that was a heart of
BY JO EATON
for their new pair. I still had a lot to learn.
My style evolved and I became bolder
with my choices. Here, it was time to prove
the twenty-year cycle wrong. In 2010, 30
years after their initial release, I happened
upon some geometric Cazal frames. They’re
deadstock and were made in 1980! I spent
many hours hunting this exact colourway on
eBay and I think my perseverance was well
worth it.
My blog started to become recognised in
the industry and I was sent glasses by a few
companies. My favourite of these were sent by
Patty Perreira of Barton Perreira fame. I loved
these so much that they were my number one
pair for over three years.
I’ve tried everything since: independent
brands, chain stores and vintage deadstock. I
even experimented with cheap online stores,
the results being mostly awful. The one
exception was a Kam Dhillon pair from Clearly
that I bought in 2011. They served me well for
a while!
During my overseas travels in 2014, I saw a
job advertised back in Melbourne at just the
kind of independent boutique I’d dreamed
about working in. I explained that I had no
optical experience. On my return, they gave
me a month trial anyway. It turned out they
needed someone fully qualified, so I didn’t get
to continue. But I loved working there so much,
that I decided to pack in my decade-long career
in digital marketing, and study the Certificate
IV in Optical Dispensing full time, at RMIT.
What about my glasses these days? I
alternate between a deadstock vintage pair
of white 1980s Martin Wells frames from
Australia and a geometric orange and gold pair
from Austrian brand Andy Wolf, but I always
keep my eyes peeled for future trends. I look
forward to sharing my insights with you here. ▀
* Jo Eaton is an optical dispensing student at RMIT.
Originally from Wellington, Jo became interested in
eyewear after discovering she was myopic at the age of
14. In 2008, many years after deciding to make unusual
glasses her ‘thing’, she founded eyewear fashion blog ‘Eye
Heart Glasses’. When she’s not immersed in the world of
spectacles, she works in digital marketing, DJs, volunteers
for community radio and is a director of feminist music
organisation LISTEN.
gold and a generous nature of spirit - and often
a cheeky little smile. If it is the mark of the man
what a difference he makes to people’s lives, then
Denis you were a very big man, as you touched the
lives of many.
On behalf of his family, I would like to thank those
people from the optical industry who attended
his funeral, DO’s (present and retired), the
president and secretary of ADONZ, wholesalers,
previous employees and board staff, it was much
appreciated and would have touched Denis. On
behalf of the industry, I pass on our condolences
to loving wife, Enid, son Bruce (DO), daughter
Gillian and family. May you take comfort from the
fact that many share your grief at the loss of a
great man.
Denis has now hung up his PD ruler, and turned
off the vert, but as always I am sure he is still
keeping a watch over what is happening in the
industry. Denis, you will be truly missed. May you
rest in peace. ▀
July 2016
NEW ZEALAND OPTICS
19

DISPENSING OPTICIAN /
OPTICAL ASSISTANT
PATERSON BURN OPTOMETRISTS HAMILTON &
SURROUNDS
We are looking for a passionate dispensing optician / optical
assistant to join our family.
In this role you will offer an amazing eye care experience by
providing exceptional customer service with honesty, care and
absolute attention to customer needs.
We offer a great working environment with continuous support
and professional development opportunities.
To be successful in this role you will:
- Have a friendly, natural and consultative approach to selling
- Be confident, enthusiastic and motivated to succeed
- Have excellent communication and sales skills
- Be a versatile team player
Experience as a dispensing optician or optical assistant is
preferred.
If you are not yet qualified, we will provide the opportunity and
support to qualify as a dispensing optician.
This position is full time, based in Hamilton and/or Cambridge
and requires some Saturday work.
To apply:
Please email your CV and a cover letter to sandri@patersonburn.
co.nz
Paterson Burn Optometrists is one of the largest independent
optometry practice groups in New Zealand. We are totally
independent and Waikato owned and we've maintained our
independence in the ever changing environment of New Zealand
optometry. Our core purpose is to improve people's lives by
providing the best visual solutions available. Paterson Burn
Optometrists value respect, integrity, accountability, enjoyment,
continuous improvement, freedom for initiative and teamwork.
NEED TO REPLACE
YOUR LETTER CHART?
AcuityKit has a comprehensive range of digital eyecharts for eyecare
professionals. Ideal for low vision and domiciliary work.
Visit our website www.acuitykit.com or email john@acuitykit.com
DISPENSING OPTICIAN/OPTICAL
ASSISTANT REQUIRED
NEED A LOCUM?
Call Bharat Raniga, locum optometrist, on
021 424 253 or email: bharatranlga@yahoo.com
EQUIPMENT FOR SALE
Chair stand, vertometer, slit lamp and other accessories for sale.
Please email bdclworks@gmail.com for further equiries.
JOIN US FOR
YOUR PERSONAL INVITATION
BRISBANE CONVENTION & EXHIBITION CENTRE
SATURDAY 10 TH & SUNDAY 11 TH SEPTEMBER 2016
Join 500 optometrists (including more than 100 non-
Specsavers optometrists) at this year’s SCC for two days
in September – for one of Australia and New Zealand’s
premier optometry CPD and networking events.
Visit spectrum-blog.com for more info
If you strive for excellence, have a keen eye for detail, great at
multitasking, enjoy working with children, then this is your
opportunity to build on your skills and join a busy practice in
Christchurch. No weekend work, no late nights. Full time position.
Please send your CV and expression of interest to
leza@anstice.co.nz
OR JOIN US FULL TIME...
With growth continuing, our store teams are currently
seeking optometrists to fill permanent roles in the following
NZ practice locations:
North Island
• Dunedin
• Invercargill
• Kerikeri
• Masterton
• Mt Maunganui
• Pakuranga
• Shirley
• Te Rapa
• Wellington CBD
South Island
• Palmerston North
• Paraparaumu
• Rotorua
• Taupo
• Tauranga
We are currently also seeking experienced dispensers for a
variety of our New Zealand stores.
Alternatively, if you’re interested in a move to Australia -
either short or longer term, talk to us for the lowdown on
possible locations in all states.
A trip to SCC as our guest could be the perfect way to see
what's on offer.
To find out more and to explore the T&C'S associated
with this industry-wide offer, contact Carly Parkinson
on 0800 717 350 or carly.parkinson@specsavers.com
– or visit spectrum-blog.com
PART-TIME DISPENSING OPTICIAN /
OPTICAL ASSISTANT, TAKAPUNA
We are looking for a dispensing optician/optical assistant to
join our independent, high-end optometry practice in Takapuna,
by the beach. The position is for 50-60 hours per fortnight –
including alternate Saturdays and Mondays.
The successful applicant will:
- Be a qualified Dispensing Optician or Optical Assistant with
dispensing experience.
- Display exceptional customer service and sales skills.
- Have a passion for fashion eyewear and leading edge lens
technology.
- Have some social media skills – e.g. Facebook, online customer
communications.
- Have flexibility to provide leave cover for our full-time
Dispensing Optician.
- Be a good team player.
If this sounds like you, please email your CV to
david@haydons.co.nz
July Classifieds FINAL NEW ZEALAND
20 NEW ZEALAND OPTICS July 2016
1